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Introduction 
 
 INTRODUCTION 
Herbal medicine 
Ever since the birth of mankind there has been a relationship between life, 
disease and plants. Primitive men started studying diseases and treatments (Lyons 
and Pertrucelli, 1987). There is no record that people in prehistoric times used 
synthetic medicines for their aliments but they tried to make use of the things they 
could easily procure. The most common thing they could find was their in 
environment i.e. the plants and animals (Singh and Abarar, 1990). They started 
using plants and found that majority of plants were suitable as food, where as other 
were either poisonous or medicinally useful. By their experience, this knowledge of 
herbal remedies was transferred to generation as folk medicine. So the history of 
herbal medicine is as old as human history. Herbal medicine is still the mainstay of 
about 75–80% of the world’s population, mainly in developing countries, for 
primary health care because of better cultural acceptability, better compatibility with 
the human body and lesser side effects. It is estimated that approximately one 
quarter of prescribed drugs contain plant extracts or active ingredients obtained from 
or modeled on plant substances. Aspirin, atropine, artimesinin, colchicine, digoxin, 
ephedrine, morphine, physostigmine, pilocarpine, quinine, quinidine, reserpine, 
taxol, tubocurarine, vincristine and vinblastine are a few important examples of what 
medicinal plants have given us in the past. Most of these plant-derived drugs were 
originally discovered through the study of traditional cures and folk knowledge of 
indigenous people and some of these could not be substituted despite the enormous 
advancement in synthetic chemistry. Consequently, plants can be described as a 
major source of medicines, not only as isolated active principles to be dispensed in 
standardized dosage form but also as crude drugs for the population. Today in many 
 countries modern medicine has displaced plants with many synthetic products but 
almost 30% of pharmaceutical preparations are still obtained directly or indirectly 
from plants. The modern era has seen some decline in use of medicinal plants and 
their extracts as therapeutic agent, particularly in developed countries, many of 
which either been discarded by the medical profession or now given in the form of 
isolated compound.  
The strategy of isolating the active principles from the medicinal plants and 
manufacturing a pharmaceutical preparation then became popular. Modern 
medicines and herbal medicines are complimentarily being used in areas for health 
care program in several developing countries including India. Of late, the interest in 
the plant products surfaces all over the world due to the belief that many herbal 
medicines are known to be free from side effects. It is the fact that the discovery of 
the new synthetic drug is time consuming & an expensive affair. The utility of the 
synthetic drug is always accompanied with its single or multiple adverse effects and 
in some cases the curatives are not available. Herbs had been used by all cultures 
throughout history but India has one of the oldest, richest and most diverse cultural 
living traditions associated with the use of medicinal plants. In the present scenario, 
the demand for herbal products is growing exponentially throughout the world and 
major pharmaceutical companies are currently conducting extensive research on 
plant materials for their potential medicinal value. In many journals, national and 
international, increasing number of research publications based on herbal drugs 
(Adithan, 1996). Plants have provided mankind a large variety of potent drugs to 
alleviate suffering from diseases in spite of spectacular advances in synthetic drugs 
in recent years, some of the drugs of plant Origin have still retained their 
importance. The use of plant-based drugs all over world is increasing. Inspite of the 
 tremendous advances made in the modern medicine there are still a large number of 
ailments for which suitable drugs are yet to be found. Today, there is an urgent need 
to develop safer drugs for the treatment of inflammatory disorders, diabetes, liver 
diseases, and gastrointestinal disorder. Hence, there is a growing interest in the 
pharmacological evaluation of various plants used in Indian traditional systems of 
medicine. However, the folkloric use of crude drugs is often empirical and is based 
on observation from clinical trials without experimental support. The need for 
exhaustive systemic research into indigenous drugs cannot be overemphasized. 
Kidney 
Figure No. 1 
 
The kidneys play key roles in body function, not only by filtering the blood 
and getting rid of waste products, but also by balancing levels of electrolyte levels in 
the body, controlling blood pressure, and stimulating the production of red blood 
cells. 
The kidneys are located in the abdomen toward the back, normally one on 
each side of the spine. They get their blood supply through the renal arteries directly 
 from the aorta and send blood back to the heart via the renal veins to the vena cava. 
(The term "renal" is derived from the Latin name for kidney.) 
The kidneys have the ability to monitor the amount of body fluid, the 
concentrations of electrolytes like sodium and potassium, and the acid-base balance 
of the body. They filter waste products of body metabolism, like urea from protein 
metabolism and uric acid from DNA breakdown. Two waste products in the blood 
can be measured: blood urea nitrogen (BUN) and creatinine (Cr). 
When blood flows to the kidney, sensors within the kidney decide how much 
water to excrete as urine, along with what concentration of electrolytes. For 
example, if a person is dehydrated from exercise or from an illness, the kidneys will 
hold onto as much water as possible and the urine becomes very concentrated. When 
adequate water is present in the body, the urine is much more dilute, and the urine 
becomes clear. This system is controlled by renin, a hormone produced in the kidney 
that is part of the fluid and blood pressure regulation systems of the body. 
Kidneys are also the source of erythropoietin in the body, a hormone that 
stimulates the bone marrow to make red blood cells. Special cells in the kidney 
monitor the oxygen concentration in blood. If oxygen levels fall, erythropoietin 
levels rise and the body starts to manufacture more red blood cells. 
After the kidneys filter blood, the urine is excreted through the ureter, a thin 
tube that connects it to the bladder. It is then stored in the bladder awaiting 
urination, when the bladder sends the urine out of the body through the urethra. 
  
Table 1: Functions of kidney 
                                                           
Major Functions of the Kidneys 
 
                                                                                                                      
Non-excretory functions 
 
Degradation of polypeptide hormones 
Insulin 
Glucagon 
Parahormone 
Prolactin 
Growth hormone 
Antidiuretic hormone 
Gastrin 
Vasoactive intestinal polypeptide 
 
Synthesis and activation of hormones 
 
Erythropoietin (stimulates erythrocyte production by bone marrow). 
Prostaglandins (vasodilators that act locally to prevent renal ischemia). 
Renin (important in regulation of blood pressure). 
 
1,25(OH2)D3 (final hydroxylation of vitamin D to its most potent 
form). 
 
                                                                                                                      
Excretory functions 
 
 
Excretion of nitrogenous end products of protein metabolism (eg, 
creatinine, uric acid, urea). 
 
Maintenance of ECF volume and blood pressure by altering Na+ 
excretion. 
Maintenance of plasma electrolyte concentration within normal range. 
Maintenance of plasma osmolality by altering water excretion. 
Maintenance of plasma pH by eliminating excess H+ and regenerating 
HCO3. 
Provision of route of excretion for most drugs. 
 
 
 
  
Hypertension and kidney damage 
The kidneys play a key role in keeping a person's blood pressure in a healthy 
range, and blood pressure, in turn, can affect the health of the kidneys. High blood 
pressure, also called hypertension, can damage the kidneys and lead to chronic 
kidney disease (CKD). 
Figure No. 2 
 
Blood pressure measures the force of blood against the walls of the blood 
vessels. Extra fluid in the body increases the amount of fluid in blood vessels and 
makes blood pressure higher. Narrow, stiff, or clogged blood vessels also raise 
blood pressure ( www.kidney.niddk.nih.gov). 
Figure No.3 
 
 Medium-sized arteries, called the renal arteries, supply the kidneys with a 
constant flow of blood that must be filtered and returned to the body’s normal 
circulation. Because the filtering functions of the kidney are mainly powered by the 
force of the blood pressure, the kidneys are very good at sensing changes in blood 
pressure. If the kidneys sense that blood pressure is dropping too low to power 
normal blood filtration, they respond by releasing hormones that act to raise blood 
pressure. 
If the flow of blood through the renal arteries decreases for any reason, the 
kidneys can be tricked into thinking that blood pressure is too low. For example, a 
disease called renal artery stenosis can cause the renal arteries to narrow, which 
decreases the amount of blood that flows into the kidneys. The kidneys detect this 
decrease and release the hormone renin in an attempt to raise blood pressure and 
restore normal blood flow. 
Problems arise when, as in renal artery stenosis, the decrease in blood flow is 
not actually caused by low blood pressure. In these cases, the kidneys end up raising 
blood pressure to very high levels in order to push more blood through the narrowed 
renal arteries. 
Genetic profile 
It is believed that most cases of hypertension leading to kidney failure have a 
genetic element (www.healthline.com). Finding a genetic link is complicated by the 
fact that nearly half of all people with renal failure have three or more serious 
disorders, such as diabetes. Animal studies have been done to find genetic linkages 
to hypertension and kidney failure, but genetic studies on humans are in their 
infancy. A recent breakthrough came in a study of African American subjects with 
 hypertensive end-stage renal disease. Researchers found a significant association 
between severe hypertension and mutations on the HSD11B2 gene. This is a gene 
that plays a role in sodium retention and related factors. Their data suggested that 
the 16q22.1 chromosome region was the location of the mutation. 
In another study, researchers studied an Israeli family of Iraqi-Jewish origin 
whose members suffered from hypertension and renal failure. The researchers found 
a genetic locus at 1q21 that was autosomal dominant. They also hypothesized that 
the gene encoding atrial natriutetic peptide receptor-1 (NPR1) was the disease gene 
that led to the hypertension/renal failure. 
Demographics 
People of all ages, races, and both sexes may develop kidney failure due to 
hypertension. However, some groups are at much greater risk than others. African 
Americans are at particularly high risk for both hypertension and renal failure and 
have four times the number of ESRD cases as Caucasians. They also experience 
kidney failure at a younger age, with an onset at about age 56 compared to an onset 
at age 62 for Caucasians. African Americans also have a higher rate of diabetes than 
non-African Americans, another reason for their increased risk for kidney failures. 
Native Americans and Alaskan Natives are also at high risk for ESRD. There are 
about the same number of males and females with newly diagnosed ESRD. 
In general, according to the National Institutes of Health, the risk for ESRD 
increases with age, and those who are over age 65 are at greatest risk for ESRD. The 
United States Renal Data Service (USRDS) of the National Institutes of Health 
tracks kidney failure statistics in the United States. According to the USRDS, in 
1998, the rate of new cases for those under age 20 was just 13 per million, and the 
 rate increased to 109 for those ages 20–44. A sharp upturn of five times that rate 
occurred in the 45–64 age group, when the rate is 545 per million people. The rate 
for those over 65 is about double, at 1,296 per million people. The mean age for 
individuals with ESRD was 62 years in 1998. 
Renal diseases 
Renal failure 
The classification of renal failure is based on two criteria: the onset (acute 
versus chronic failure) and the location that precipitates nephron destruction 
(prerenal, renal or instrinsic, and postrenal failure). Chronic renal failure is a slow, 
irreversible, and progressive process that occurs over a period of years whereas 
acute renal failure develops over a period of days or weeks. The distinction between 
acute and chronic disease is important; acute disease is usually reversible if managed 
appropriately whereas chronic renal failure is a progressive and irreversible process 
that leads to death in the absence of medical intervention. In both cases, the kidneys 
lose their normal ability to maintain the normal composition and volume of bodily 
fluids. Although the terminal functional disabilities of the acute and chronic diseases 
are similar, acute renal failure has some unique aspects 
Acute Renal Failure 
Acute renal failure (ARF) is a clinical syndrome characterized by a rapid 
decline in kidney function over a period of days to weeks, leading to severe 
azotemia (the building up of nitrogenous waste products in the blood). It is very 
common in hospitalized patients; ARF occurs in up to 5% of all admitted patients 
and in as many as 30% of patients admitted to intensive care units. Medications, 
surgery, pregnancy-related complications, and trauma are the most common causes 
 of ARF. Unlike patients who undergo chronic renal failure, patients who develop 
ARF usually have a normal baseline renal function; yet, mortality from ARF (even 
with medical intervention including dialysis) can reach 80%, demonstrating the 
critical illness of these patients (Thadhani et al., 1996). The clinical course of acute 
renal failure most often progresses through three stages: oliguria (urine volume < 
400 mL per day), diuresis (high urine volume output > 400 mL per day), and 
ultimately, recovery (Racusen, 1997). The causes of ARF are often divided into 
three diagnostic categories: prerenal failure, postrenal failure, and acute intrinsic 
renal failure. 
Prerenal failure 
Prerenal failure, defined as any condition that compromises renal function 
without permanent physical injury to the kidney, is the most common cause of 
hospital-acquired renal failure. This condition, often referred to as prerenal 
azotemia, results from reversible changes in renal blood flow and is the most 
common cause of acute renal failure, accounting for more than 50% of cases 
(Dishart et al., 2000). Some etiologic factors commonly associated with prerenal 
failure include volume depletion, cardiovascular diseases that result in diminished 
cardiac output, and changes in fluid volume distribution that are associated with 
sepsis and burns (Wardle, 1994). 
Postrenal failure 
Postrenal causes of failure are less common (< 5% of patients) than prerenal 
causes. Postrenal failure refers to conditions that obstruct the flow of urine from the 
kidneys at any level of the urinary tract and that subsequently decrease the GFR. 
Postrenal failure can cause almost total anuria with complete obstruction or polyuria. 
Renal ultrasonography often shows a dilated collecting system (hydronephrosis). 
 Most commonly, obstruction results from prostatic enlargement (benign hypertrophy 
or malignant neoplasia) or cervical cancer. It is usually seen in older men as a result 
of the enlargement of the prostate gland. Although postrenal failure is the least 
common cause of acute renal failure, it remains the most treatable. 
Acute intrinsic renal failure 
Glomerular disease, vascular disease, and tubuleinterstitial disease comprise 
the three major causes of acute intrinsic renal failure and describe the sites of 
pathology. Glomerulonephritis is an uncommon cause of acute renal failure and 
usually follows a more subacute or chronic course. However, when fulminant 
enough to cause acute failure, it is associated with active urinary sediment. 
Prominent clinical and laboratory findings include hypertension, proteinuria, 
hematuria, and red blood cell casts. Postinfectious, membranoproliferative, and 
rapidly progressive glomerulonephritis, as well as glomerulonephritis associated 
with endocarditis and infections of the vascular access, are the most common 
glomerular diseases to cause a sudden renal deterioration. The pathogenesis of 
glomerulonephritis appears to be related to the immunocomplex and complement-
mediated damage of the kidney (Kashtan, 1999). Vascular occlusive processes such 
as renial arterial or venous thromboses are also causes of acute intrinsic renal failure. 
The clinical presentation is archetypal, consisting of a triad of severe and sudden 
lower back pain, severe oliguria, and macroscopic hematuria. By far, the most 
common causes of acute intrinsic failure are tubulointerstitial disorders (> 75% of 
cases), including interstitial nephritis and acute tubular necrosis (ATN). Infiltrative 
diseases (such as lymphoma or sarcoidosis), infections (such as syphilis and 
toxoplasmosis), and medications are the leading causes of interstitial nephritis. With 
drug-induced interstitial nephritis, there are accompanying systemic signs of a 
 hypersensitivity reaction, and the presence of eosinophils is a common finding in the 
urine. Although renal function returns to normal with the discontinuation of the 
offending drug, recovery may be hastened with corticosteroid therapy (Meyers, 
1999). ATN is a renal lesion that forms in response to prolonged ischemia or 
exposure to a nephrotoxin (Lieberthal and Nigam, 2000). ATN remains more of a 
clinical diagnosis of exclusion than a pathologic diagnosis. The period of renal 
failure associated with ATN can range from weeks to months, and the major 
complications of this transient failure are infections, imbalances in fluid and 
electrolytes, and uremia. Serum levels of BUN and creatinine peak, plateau, and 
slowly fall, accompanied by a return of renal function over 10 to 14 days in most 
cases (Bennett, 1999). Sudden renal failure in hospitalized patients is often very 
apparent from either oliguria or a rise in BUN and creatinine levels.However, renal 
dysfunction in the outpatient population is often more subtle. A patient can present 
to the dental office with vague complaints of lethargy and fatigue or entirely without 
symptoms. These patients can often go undiagnosed but for abnormal results on 
routine urinalysis, the most common test for screening for renal disease (Jungers, 
1999 and Rahman et al., 1998). 
Chronic Renal Failure 
Chronic renal failure (CRF) can be caused by many diseases that devastate 
the nephron mass of the kidneys. Most of these conditions involve diffuse bilateral 
destruction of the renal parenchyma. Some renal conditions affect the glomerulus 
(glomerulonephritis), others involve the renal tubules (polycystic kidney disease or 
pyelonephritis), while others interfere with blood perfusion to the renal parenchyma 
(nephrosclerosis). Ultimately, nephron destruction ensues in all cases unless this 
process is interrupted. The prognosis of the patient with renal disease has improved 
 significantly during the last two decades. The improvement of antimicrobial therapy 
to combat increased susceptibility to infection, along with advances in dialysis and 
transplantation techniques, has provided patients with the opportunity for survival in 
the face of a complete loss of renal function. 
The clinical course of CRF is divided into three progressive stages: (1) 
diminished renal reserve, (2) renal insufficiency, and (3) end-stage renal failure or 
uremia. Diminished renal reserve is characterized by normal serum creatinine and 
BUN levels. There are no symptoms or prominent biochemical disturbances. Renal 
impairment may be detected only when severe demands are being placed on the 
kidneys or by sophisticated testing of the GFR. The second clinical stage, renal 
insufficiency, occurs when the GFR drops to 25% of normal (> 75% of functional 
kidney tissue has then been destroyed). As nephron destruction progresses, the GFR 
falls, and the BUN level rises. Among the consequences are (usually) mild azotemia, 
nocturia, polyuria, and an impaired ability to concentrate urine. The third and final 
stage of chronic renal failure is end-stage renal failure or uremia.With continued 
destruction of nephrons (destruction of > 90% of nephron mass), frank renal disease 
follows, with associated polyuria. The GFR is 10% of normal, and creatinine 
clearance may be 5 to 10 ml/min or less. Sharp increases in serum creatinine and 
BUN are seen in response to small decrements in the GFR. At this point, patients 
experience severe symptoms as their kidneys cannot maintain fluid and electrolyte 
homeostasis. The complex biochemical changes, including anemia, hypocalcemia, 
hyperphosphatemia, and metabolic acidosis, along with vast systemic symptoms, a 
patient experiences, has been termed “uremic syndrome”. Without renal replacement 
therapy, death is a certain consequence. 
 The progression of the varied renal diseases, culminating in chronic renal 
failure, ranges from a few months to 30 to 40 years. Currently, diabetes and 
hypertension account for 44.4% and 26.6%, respectively, of the total cases of ESRD. 
Glomerulonephritis is the third most common cause of ESRD (12.2% of cases). 
Interstitial nephritis, pyelonephritis, and polycystic kidney disease account for 7.2% 
of cases. The remaining 9.6% of the causes of ESRD include systemic lupus 
erythematosus (SLE) and relatively uncommon conditions such as obstructive 
uropathy. 
Glomerulonephritis  
Glomerulonephritis represents a heterogeneous group of diseases of varying 
etiology and pathogenesis that produce irreversible impairment of renal function. 
This is often initiated by an attack of acute glomerulonephritis of streptococcal or 
nonstreptococcal origin. Glomerulonephritis also may enter the chronic stage from a 
nephritic syndrome. The most typical examples of this are idiopathic membranous 
glomerulonephritis and membranoproliferative glomerulonephritis (Levin, 1999). In 
most cases, the patients present with the features of CRF and hypertension or with a 
chance proteinuria that has progressed to chronic nephritis over a period of years. 
Chronic glomerulonephritis is usually insidious in onset. 
The course is very slow but is steadily progressive, leading to renal failure 
and uremia in up to 30 years. It is thought to be a disorder of immunologic origin. 
The continuous nature of the immunologic injury is shown by the recurrence of 
disease in kidneys that have been transplanted to patients with some type of 
glomerulonephritis, even after their own kidneys had been removed (Couser, 1999). 
  
Nephrotic Syndrome  
Nephrotic syndrome is the clinical manifestation of any glomerular lesion 
that causes an excess of more than 3 g of protein excretion in the urine per day. 
Nephrotic syndrome is caused by multiple diseases, all of which enhance the 
permeability of the glomerulus to plasma proteins. Excessive protein excretion leads 
to a decline of plasma osmotic pressure, with consequent edema and serosal 
effusions. The differential diagnosis of nephrotic syndrome is vast but includes 
sickle cell anemia, diabetes mellitus, multiple myeloma, SLE, and membranous 
glomerulonephritis. Bacterial infections secondary to hypogammaglobulinemia have 
been described as a cause of death in children with nephrotic syndrome. 
Pyelonephritis 
Pyelonephritis refers to the effects of bacterial infection in the kidney, with 
Escherichia coli being the most frequent cause of infection (Roberts, 1991). 
Pyelonephritis may present in an acute form with active pyogenic infection or in a 
chronic form in which the principal manifestations are caused by an injury sustained 
during a preceding infection. The chronic form of bacterial pyelonephritis can be 
further subdivided into reactive and inactive forms, and one or both kidneys may be 
affected. Any lesion that produces an obstruction of the urinary tract can predispose 
to active pyelonephritis. Pyelonephritis also may occur as part of a generalized 
sepsis as seen in patients with bacterial endocarditis or staphylococcal septicemia. 
The clinical picture of acute pyelonephritis is often characteristic, consisting 
of a sudden rise in body temperature (to 38.9° to 40.6°C), shaking chills, aching pain 
in one or both costovertebral areas or flanks, and symptoms of bladder 
inflammation. Microscopic evaluation of the urine reveals large numbers of bacteria 
 and a polymorphonuclear leukocytosis. There are no signs of impaired renal 
function or acute hypertension as is sometimes seen in patients with acute 
glomerulonephritis. Patients with chronic active pyelonephritis often suffer from 
recurrent episodes of acute pyelonephritis or may have persistent smoldering 
infections that gradually result in endstage renal failure secondary to destruction 
from the scarring of renal parenchyma. This process may continue for many years. 
The inability to conserve sodium (a feature in any patient with impaired renal 
function) is more pronounced in patients with pyelonephritis than in those with 
glomerulonephritis. This “salt-losing” defect may be pronounced and may dominate 
the clinical picture. 
Polycystic Renal Disease 
Polycystic kidney disease exhibits autosomal dominant inheritance (Avner et 
al., 1999). Most patients present with microscopic or gross hematuria, abdominal or 
flank pain, and recurrent urinary tract infections. The disease causes renal 
insufficiency in 50% of individuals by age 70 years (Wilson and Woodford, 1999). 
Clinically, these patients have large palpable kidneys, and the diagnosis is confirmed 
via renal ultrasonography, CT, or IVP.Most patients develop hypertension during 
the course of their disease, and more than one-half of patients are hypertensive at the 
time of presentation. Although no preventive therapies have proven to be effective, 
treating the hypertension with angiotensin-converting enzyme inhibitors may help to 
slow the progression of polycystic disease. Another form of polycystic kidney 
disease is an acquired reactive process that is seen in over 50% of patients treated by 
hemodialysis or peritoneal dialysis for longer than 3 years. The development of 
adenocarcinomas is seen in approximately 5% of these multiple cysts throughout the 
remnant kidneys. 
 
  
Hypertensive Nephrosclerosis  
The association between the kidneys and hypertension is recognized, yet the 
primary disease often is not. Hypertension may be the primary disorder damaging 
the kidneys, but conversely, severe chronic renal failure may lead to hypertension or 
perpetuate it through changes in sodium and water excretion and/or in the 
reninangiotensin system (Townsend and Cirigliano, 1998). Hypertension remains 
one of the leading causes of chronic renal failure, especially in nonwhite 
populations.  The heart, brain, eyes, and kidneys comprise the four major target 
organs of hypertension. Long-standing hypertension leads to fibrosis and sclerosis of 
the arterioles in these organs and throughout the body. Benign nephrosclerosis 
results from arteriosclerotic changes due to long-standing hypertension. It is the 
direct result of ischemia caused by narrowing of the lumina of the intrarenal 
vascular supply. The progressive closing of the arteries and arterioles leads to 
atrophy of the tubules and destruction of the glomerulus. “Malignant 
nephrosclerosis” refers to the structural changes that are associated with the 
malignant phase of essential hypertension. 
Connective-Tissue Disorders.  
Renal diseases are very prevalent among patients with connective-tissue 
disorders, commonly referred to as collagen vascular diseases. Approximately two-
thirds of patients with SLE and scleroderma or progressive systemic sclerosis (PSS) 
have clinical evidence of renal involvement. In rheumatoid arthritis, the prevalence 
of renal involvement is considerably less and is often related to complications of 
treatment with gold salts or D-penicillamine. 
  
Metabolic Disorders  
The most common metabolic disorders that may lead to CRF include 
diabetes mellitus (DM), amyloidosis, gout, and primary hyperparathyroidism. By 
far, diabetes mellitus is one of the most important causes of CRF and accounts for 
nearly one-half of new ESRD patients (data from US Renal Data System, 1999). 
The type of diabetes the patient has affects the probability that the patient will 
develop ESRD. It has been estimated that about 50% of patients with type 1 DM 
develop ESRD within 15 to 25 years after the onset of diabetes, compared to 6% for 
patients with type 2 DM. The term “diabetic nephropathy” refers to the various 
changes that affect the structure and function of the kidneys in the presence of 
diabetes. Glomerulosclerosis is the most characteristic lesion of diabetic 
nephropathy. Other lesions include chronic tubulointerstitial nephritis, papillary 
necrosis, and ischemia. The natural progression of diabetic nephropathy follows five 
stages, beginning with early functional changes (stage 1) and progressing through 
early structural changes (stage 2), incipient nephropathy (stage 3), clinical diabetic 
nephropathy (stage 4), and finally, progressive renal insufficiency or failure (stage 
5). The final stage is characterized by azotemia (elevated BUN and serum 
creatinine) resulting from a rapid decline in the GFR and leading to ESRD. 
Toxic Nephropathy  
The kidney is particularly exposed to the toxic effects of chemicals and drugs 
because it is an obligatory route of excretion for most drugs and because of its large 
vascular perfusion (Bennett, 1997). There are medications and other agents (referred 
to as “classic”nephrotoxins) whose use leads directly to renal failure. However, 
abuse of nonsteroidal anti-inflammatory drugs (NSAIDs) can also result in CRF. 
 The renal protective effects of prostaglandins are inhibited by NSAIDs. Currently, 
abuse of analgesics accounts for 1 to 2% of all ESRD cases in the United States. 
Signs and Symptoms 
The symptoms of kidney disease include: 
¾ High/worsening blood pressure 
¾ Decrease in amount of urine or difficulty urinating 
¾ Edema (fluid retention), especially in the lower legs 
¾ A need to urinate more often, especially at night 
¾ A failure to eat (anorexia) and skin color changes such as a change to a 
yellow-brown skin color. 
¾ Urea from perspiration may appear on the skin as whitish crystals, similar to 
frost. 
¾ Pruritis (severe itching of the skin) is common. 
¾ Patients may have muscle cramps and convulsions.  
¾ Many have malnutrition from anorexia and vomiting.  
¾ Gastric ulcers are common, as are cardiac symptoms stemming from the 
retention of sodium and water. 
¾ Anemia (low levels of iron in the blood) is also common. 
Diagnosis 
¾ Very high blood pressure in people younger than 30 
¾ Sudden onset of very high blood pressure in people older than 55 
¾ Blood pressure that does not respond to drug treatment 
¾ Blood pressure that stops responding to previously effective treatments 
 ¾ Blood tests are usually done in suspected cases of renovascular hypertension, 
but the only sure way to diagnose the problem is to actually see a narrowing 
of the renal arteries. This is usually done with a non-invasive procedure such 
as an MRI or CT scan, but sometimes more invasive measures are required. 
In these cases, a small catheter is threaded through the groin into the renal 
artery itself, and small amounts of dye are released from the catheter tip.  
¾ A person's glomerular filtration rate (GFR) is a measure of how well the 
kidneys are filtering wastes from the blood. GFR is estimated from a routine 
measurement of creatinine in the blood. The result is called the estimated 
GFR (e GFR). 
¾ An e GFR with a value below 60 milliliters per minute (mL/min) suggests 
some kidney damage has occurred.  
¾ Creatinine is a waste product formed by the normal breakdown of muscle 
cells. Healthy kidneys take creatinine out of the blood and put it into the 
urine to leave the body. When the kidneys are not working well, creatinine 
builds up in the blood. 
¾ Another sign of CKD is proteinuria, or protein in the urine. Healthy kidneys 
take wastes out of the blood but leave protein. Impaired kidneys may fail to 
separate a blood protein called albumin from the wastes. At first, only small 
amounts of albumin may leak into the urine, a condition known as 
microalbuminuria, a sign of failing kidney function. As kidney function 
worsens, the amount of albumin and other proteins in the urine increases, and 
the condition is called proteinuria. CKD is present when more than 30 
milligrams of albumin per gram of creatinine is excreted in urine, with or 
without decreased eGFR. 
 Prevention of kidney damage from hypertension 
To prevent kidney damage from high blood pressure: 
¾ Try to keep blood pressure controlled. 
¾ Blood pressure checked on a regular basis. 
¾ Eat a proper diet. 
¾ Get moderate exercise, such as walking, 30 minutes daily. 
¾ Take the medication - doctor prescribes. 
Treatment and Management 
¾ Anemia is treated and transfusions are given if anemia is severe. 
¾  ACE inhibitor drugs may be prescribed at low doses to treat cardiac 
symptoms.  
¾ Diuretics may be prescribed to reduce fluid retention. 
¾  Multivitamins may be recommended because of food restrictions. 
¾ Patients with kidney failure, despite the cause of the failure, must receive 
kidney dialysis or kidney transplantation. Eventually, those on dialysis will 
require transplantation of a kidney, either from a recently deceased person or 
a live donor. (Each person has two kidneys and can live normally with only 
one kidney.) About 13,000 kidney transplants are performed in the United 
States each year and about 47,000 people wait for a donated kidney per year. 
¾ There are two types of dialysis. The most common type of treatment is 
"hemodialysis," a procedure that uses a machine called a dialyzer to clean 
and filter the blood, since the kidneys can no longer perform that function. A 
connection from the machine is made to the patient's bloodstream and the 
blood travels through the dialyzer where it is cleaned for 2–4 hours. This 
 procedure is generally performed three times a week. Patients must also 
change their diets to carefully limit the amount of salt, potassium, and fluids 
that are consumed, among other dietary restrictions that are given. 
¾ “Peritoneal dialysis” is another option for patients with kidney failure. In this 
procedure, the patient's own abdominal lining (the peritoneal membrane) is 
used to help clean the blood. Rather than the patient’s own blood traveling to 
a machine, as with a dialyzer, a cleansing solution is transferred through a 
special tube (catheter) directly into the body. The catheter remains in the 
body. The number of treatments and time to perform the cleansing 
procedures vary. 
      Herbal medicines for kidney failure                                                                                                   
Herbs Parts Used Chemical Constituents 
Aerva javanica Fresh Roots Isoquercetin, 5 methylmellein and 
Kaempferol (Movaliyaa et al., 
2011). 
Aerva lanata Whole plant Botulin, β-sitosterol, Amyrin, 
Hentriacontane, Campesterol 
(Shirwaikar et al., 2004). 
Bauhinia variegatea linn Stems stigmasterol, flavone glycosides, 
lupeol, β-setosterol (Saumya et al., 
2011). 
Cassia auriculata Roots Tannins, Di-(2-ethyl) hexyl 
phthalate, Alkaloids, Resins 
(Saumya et al., 2005). 
  
Carica papaya Seeds Flavonoids, Phenols, Alkaloids, 
Protein, Sterols, Terpenoids, 
Terpenes and Saponins (Movaliyaa 
et al., 2011). 
Ceratonia silique Pods and 
Leaves 
Flavonoids (Ahmed, 2010). 
Cucurbita pepo Seeds Flavonoids, Phenols, Alkaloids, 
Protein, Sterols, Terpenoids, 
Carbohydrates, Terpenes and 
Saponins 
Dichrostachys cinera Roots Fixed oils, Steroids, Flavonoids, 
Friedlen and α amyrin (Adikay et 
al., 2009). 
Ficus religiosa Latex Amino acids and Tannins (Yadav  
et al., 2011). 
Kigelia Africana Matured fruits Iridoids, Naphthoquinones, 
Flavonoids, Terpenes, 
Saponins and Caffeic acid (Azu et 
al., 2010). 
Lepidium sativum Seeds Vitamin B-carotene, Riboflavine, 
Niacin, Flavonoids ,  Glycosides 
and Isothiocynates (Chandyadav et 
al., 2010). 
Panax ginseng Roots Ginsenosides (Dammarol), 
Panaxosides (Oleanolic acid) and 
Chikusetsu saponin 
(http://farmacists.blogspot.com). 
Picrorhiza kurroa Royle Rhizome Tannins (Yamgar et al., 2010). 
Pongamia pinnata Flowers Alkaloids, Tannins, Sugar 
(http://farmacists.blogspot.com). 
Salviae radix Whole plant Salvianolic acid A-G, Rosmarinic 
acid, Lithospermic acid, Isoferulic 
acid  
Vernonia cinerea Aerial parts Triterpenoids like α-amyrin, β-
amyrin and lupeol (Sreedevi et al., 
 2011). 
Aegle marmelos Leaves Mamesinine, Lupeol, Tannins, 
Phlobatannins, Flavonoids, 
Umbelliferone, Quercetin and 
Volatile oils (Kore et al., 2011). 
Crataeva nurvula Fruits Kaemferol-3-O-a-D-glucoside, 
Quercitin-3-O-a-D-glucoside, 
Flavonoids, Glucosinolates, 
Steroids, Lupeol and Tannins. 
Emblica officinalis Fruits Darabinosyl, D-xylosyl, L-
rhamnosyl, G-glycosyl, D-manosyl, 
D-galactosyl, Embicol, Mucic and 
Phyllambic acid. 
Glycyrrhiza glabra Rhizomes Glycyrrhizin, Glyciyrrhizic acid, 
Glycosides, Steroids, Glucose, 
Sucrose, Resin, Starch and Essential 
oil 
Hygrophilaspinosa Whole plants Β-sitosterol, Lupeol, Minerals like 
Anders6 Plant Na, K, Ca, P and 
Poluphenols (Bibu et al., 2010) 
Kalanchoe pinnata Pars Leaves Tricontane, Alpha & Beta Amyrin, 
Beta-Sitosterol, Fumaric acid, 
Mallic acid and Calcium Oxalate 
(Harlalka et al., 2007). 
Morinda citrifolia L Fruit Americanoic acid A, Morindolin 
and Isoprincepin (Shenoy et al., 
2011). 
Nigella sativa Whole plant Alanine, L-Spinasterol, Arabic acid, 
Arginine, Amino acid, Aspargine, 
Aspartic acid, Carvone, Cystine 
Ocimum sanctum Leaves Apigenin, Luteolin, Ascorbic acid, 
Carotene, Alkaloids, Glycosides,  
 
Saponins and Tannins (Kannappan 
et al., 2010). 
Orthosiphon stamineus Whole plant Steroids, Tannins, Glycosides, 
Terpins and Saponins (Kannappan 
et al., 2010) 
  
Rhazya stricta Leaves 1-carbomethoxy-β-carboline, 
Condyloacarpine and Vincanicine 
Solanum nigrum Whole plant Glucose, Fructose, 
Caffeicsolasodine, Tamatidenol, 
Solamargine, Solasomine, 
Trigogenine, Pottasium, Sulphur, 
Calcium and Phosphorous. 
Strychnos potatorum Seeds Flavanoids, Phenols, Saponins, 
Alkaloids, Steroids, Tannins, 
Glycosides, and Lignins (Varghese 
et al., 2011) 
Tribulus sativus Fruits Flavanoids, Kaemferol, Tribuloside, 
Fixed oil, Resin, Essential oil and 
Nitrates 
Withania somnifera Roots Amino acids, Essential Oils, 
Withaniol, Hexatriacontane, Phyto 
sterol and oils. 
Pedalium murex Linn Dried fruits Flavanoids, Flavones, Alkaloids, 
Triterpenoids, Carbohydrates, 
Glycosides, and Saponins (Shelke et 
al., 2009) 
Acorus calamus Aerial Parts Monoterpene, Sesquiterpene, 
Phenyl propanoid, Flavonoid, 
Quinone and basarone (Palani et al., 
2010). 
Boerhaaviadiffusa Root Flavonoids, Alkaloids, Steroids, 
Triterpenoids, Lipids, Lignins, 
Carbohydrates, Proteins and 
Glycoproteins (Surendra et al., 
2011). 
Caranarium schweinfurthii Stem Bark Octylacetate, Nerolidol, 
Protein,Starch, Cellulose, K, Ca, 
Oleic acid and Stearic acid 
(Okwuosa et al., 2009). 
  
ClitoriaternateaLin Aerial parts Varidiflorene, Pterocarpin, 
6HBenzofuro[ 3,2-c][1] 
benzopyran, Isoparvifuran, 
Hexadecanoic acid, 1, 2, 3 , 5- 
Cyclohexanetetrol and Propane 
(Sarumathy et al., 2011). 
DioscoreaalataL Whole Plant Dioscorine, Starch, Vitamin-B, 
Calcium Oxalate, Protien and Iron 
(Shih-Chang et al., 2002). 
Harunganamadaga 
scariensis(L) 
 
Fresh Root Feruginin, Harunganin, 
Harunganelol A, B, Friebelan 3-one 
and Betlinic acid (Adeneye et al., 
2008). 
IndigoferabarberiL Whole plant Flavonoids, Phenolic acid and 
sterols (Palani et al., 2008). 
Monochoria vaginalis Aerial Parts 3- trifluoroacetoxy pentadecane and 
4- ethyl-5-octyl-2,2-bis 
(trifluoromethyl) - cis-1,3-dioxalone 
(Palani et al., 2011). 
Pimpinella tirupatiensis Whole plant Volatile oils, β-Bisaboline, Δ-3-
Carene, Cis-Carveol, Enemol, Δ-
Carveol and Methylgeranate (Palani 
et al., 2010) 
ZingiberzerumbelSmith Rhizome Zerumbone, Afzelin, 
Diacetylafzelin, derivatives of 
kaemferol and 3- flavonol (Hamid 
et al., 2011). 
ZingiberOfficinaleroscoe Rhizome Volatile oil, Gingerol, Shogaol, 
Resins, Starch, Fibres, Capsaicin 
and Paradol (Ajith et al., 2008). 
RubiacordifoliaLinn. Root Purpurin, Manjistin, Garancin,   
Purpuroxanthin, Resin, Fattyacids 
and Gum (Divakar et al., 2010). 
Vitisvenefera L. Seed Gallocatechin, Abscisic acid, Acetic 
acid, A-Hemicellulose, Alanine, α- 
Viniferin, α- tocoferol. 
  
 
 
 
Curcuma longa Rhizome Curcumin, Termeric oil, 
Terpenoids, Curcumen(Terpene), 
Starch and Albumnoids (Jijon et al., 
2011). 
BrideliaretusaSpreng Bark Arpodomapuic acid, 5 Allyl 1,2,3 
trimethoxy benzene (or) Elemicin 
and +Sesamin (Cordeirom and  
Kaliwalb, 2011). 
Drynaria fortune Whole plant Arsenic, Ca2+, Cu2+, Glucose, 
Iron, Mg, Mn, Hg, Naringin, K+, 
Na+, Starch and Zinc 
Eruca sativa Seeds Flavanoids (Alam et al., 2007). 
Moringa oleifera Seeds Sucrose, Citric acid, Malic acid, 
Succinic acid, Fumaric acid and 
Oxalic acid (Ranjan et al., 2009).  
Tamirindus indica Fruit Pulp Ethanollamine, Serine, Inositol, 
Alkaloid, Citric acid, Tartaric acid 
and Pottasiumbitartrate (Ranjan et 
al., 2009). 
PunicagranatumL Fruit peel Ellagic acid, Ellagitannins and 
gallic acid (Mohammed et al., 
2010). 
Euphorbia neriifolia Leaves Saponins, Flavonoids and Tannins 
(Pracheta et al., 2011). 
Tectona grandis Bark Lapachol, Dehydro-α-lapachone, 
Methyl quinizarin and Squalene 
(Ghaisas et al., 2010). 
Ginkgo biloba Whole plant Flavonoids, Bilobalide, Gingkolide 
A, Gingkolide B and Gingkolide 
CandBiflanoide (Welta et al., 
2007). 
  
 
 
 
 
Herbs Uses 
Cordyceps sinensis Improving the regeneration of renal 
tubular epithelial cells 
Salvia miltiorrhiza Increase the blood flow on the kidney 
Rheum Officinale Used to reduce elevated serum creatinine 
level and high blood urea nitrogen level 
Astragalus Mmngholicus Correcting patients’ immune sysdtem and 
giving a good internal environment to 
kidney 
Punarnava (Boerhavia diffusa) It helps in removing excess water from the 
body due to kidney failure. 
(www.planetayurveda.com). 
Varun (Crataeva nurvala) It is very effective for obstruction in 
urinary tract and helps in removing the 
renal stones. 
Gokshur (Tribulus terrestris) It clears away the obstruction in the 
urinary tract and is also act as anti-
infective. It also helps to avoid dialysis. 
Rakt Chandan (P. santalinus- Red 
Sandalwood) 
It acts like a cooling agent in the urinary 
tract and is a urinary alkaliser. 
Palaash (Butea monosperma) It is a urinary alkaliser and also relieves 
painful micturition. 
Kaasni (Cichorium intybus) It is useful in Nephrotic syndrome, 
nephritis and other conditions leading to 
kidney failure. 
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 PLANT PROFILE 
 
Citrullus lanatus 
Kingdom    : Plantae - Plants 
Subkingdom : Tracheobionta – Vascular plants 
Superdivision : Spermatophyta – Seed plants 
Division : Magnoliophyta – Flowering plants 
Class : Magnoliopsida – Dicotyledons 
Subclass : Dilleniidae 
Order : Cucurbitales 
Family : Cucurbitaceae –Cucumber family 
Genus : Citrullus Schrad. – watermelon  
Species : Citrullus lanatus (Thunb.) Matsum. & Nakai –  
  watermelon  
 Variety                     : Citrullus lanatus (Thunb.) Matsum. & Nakai var.lanatus –     
  watermelon                       
Scientific name       : Citrullus lanatus 
Synonym                 : Citrullus vulgaris 
English     : Watermelon    
Crop categories 
Fruits  
Food crops 
Tropical crops 
Basic information and facts 
Origin: 
Southern Africa 
Distribution: 
Now grown in most tropical and sub-tropical regions of the world. 
Flowers: 
Flowers are five-petaled with a light yellow color. Plants produce both male 
and female flowers.  Flowers are usually 2 to 3 cm in diameter. 
Leaves: 
The leaves are deeply lobed and have a dark grayish green color. They are 
covered with soft downy hairs. 
  
Figure No. 4 Fruits: 
 
The big round or oval fruits have a thick rind and a fleshy center, usually 
with many dark brown to black seeds. The fruits has a green and yellow color on the 
outside. The flesh inside is usually red, but color variations include type with yellow 
or orange flesh. Fruits can weigh from 2 to 20 kilos, depending on the variety. 
Climate and weather: 
Tropical and sub-tropical climates. Watermelon prefers a hot, dry climate 
(daily temperatures between 22 to 30°C). It can survive desert conditions when 
groundwater is available. 
Fruit development: 
Watermelon fruits that are grown under hot and dry conditions have a higher 
sugar content than fruits that grew up under cool and humid conditions. 
Harvesting: 
Harvest by hand when the fruits have fully ripened. 
  
Nutrition: 
A watermelon contains about 6% sugar and 92% water by weight. As with many 
other fruits, it is a source of vitamin C. 
Table 2: 
Watermelon, raw (edible parts) 
Nutritional value per 100 g (3.5 oz) 
Energy 127 kJ (30 kcal) Niacin (vit. B3) 0.178 mg (1%) 
Carbohydrates 7.55 g Pantothenic acid (B5) 0.221 mg (4%) 
Sugars 6.2 g Vitamin B6 0.045 mg (3%) 
 Dietary fiber 0.4 g Folate (vit. B9) 3 μg (1%) 
Fat 0.15 g Vitamin C 8.1 mg (10%) 
Protein 0.61 g Calcium 7 mg (1%) 
Water 91.45 g Iron 0.24 mg (2%) 
Vitamin A equiv. 28 μg (4%) Magnesium 10 mg (3%) 
Thiamine (vit. B1) 0.033 mg (3%) Phosphorus 11 mg (2%) 
Riboflavin (vit. B2) 0.021 mg (2%) Potassium 112 mg (2%) 
 
Nutritional Values of water melon: 
¾ Water melon sugar consist of sucrose, glucose and fructose. 
¾ It also contains vitamins like A, B6, C, PP, folacin and carotene. 
¾ 100 gms of water melon contains 38 calories 
¾ Watermelon contains the highest amount of lycopene. 
 ¾ It contains Argenine an amino acid. 
Health benefits of watermelon 
¾ The Rich in electrolytes and water content, melons are nature’s gift to beat 
tropical summer thirst. 
¾ Watermelons are very low in calories (just 30 calories per 100 g) and fats yet 
very rich source of numerous health promoting phyto-nutrients and anti-
oxidants that are essential for optimum health. 
¾ Watermelon is an excellent source of Vitamin-A, which is a powerful natural 
anti-oxidant. 100 g fresh fruit provides 569 mg or 19% of daily-required 
levels of this vitamin. It is essential for vision and immunity. Vitamin-A is 
also required for maintaining healthy mucus membranes and skin. 
Consumption of natural fruits rich in vitamin-A is known to protect from 
lung and oral cavity cancers. 
¾ It is also rich in anti-oxidant flavonoids like lycopene, beta‐carotene, lutein, 
zeaxanthin and cryptoxanthin. These antioxidants are found to offer 
protection against colon, prostate, breast, endometrial, lung, and pancreatic 
cancers. Phyto-chemicals present in watermelon like lycopene and 
carotenoids have the ability to help protect cells and other structures in the 
body from oxygen-free radicals.  
¾ Watermelon is an excellent source of carotenoid pigment, lycopene and 
indeed, superior to raw red tomato. 100 g of fresh melon provides 4532 µg 
lycopene, whereas only 2573 µg in tomatoes. Studies suggest that lycopene 
offer certain protection to skin from harmful UV rays. 
 ¾ Watermelon fruit is a good source of potassium; Potassium is an important 
component of cell and body fluids that helps controlling heart rate and blood 
pressure; It thus offers protection against stroke and coronary heart diseases. 
¾ Furthermore, it contains a good amount of vitamin-B6 (pyridoxine), thiamine 
(vitamin B-1), vitamin-C, and manganese. Consumption of foods rich in 
vitamin-C helps the body develop resistance against infectious agents and 
scavenge harmful oxygen-free radicals. Manganese is used by the body as a 
co-factor for the antioxidant enzyme, superoxide dismutase. 
¾ Total measured antioxidant strength (ORAC value) of watermelon is 142 
µmol TE/100 g. 
¾ Watermelon is a less fat fruit, having low calories, and it is an ideal diet 
food. 
¾ Argenine relaxes blood vessels. It also improves muscle growth, stimulating 
a good immune system. 
¾ Arginine also helps the urea cycle, by removing ammonia and other toxic 
compounds from our body. 
¾ Watermelon contains lycopene an anti-oxidant that may help to prevent 
diseases like cancer. 
¾ It does not have cholestral. 
¾ In liver diseases, it’s good to drink watermelon juice because it will take the 
liquid from organism. 
¾ Watermelon can also be used to treat anemia, calculi formation. 
 ¾ Watermelon contains lot of potassium, which is helpful in cleaning the toxic 
depositions in the kidney. 
¾ The potassium and magnesium in the watermelon helps in reducing the high 
blood pressure to normal ones. 
¾ Watermelon’s cleansing and nourishing face packs. 
¾ Take watermelon’s pulp and have a paste and apply it on face for 15minutes, 
and wash it off, it leaves skin beautiful and soft. 
¾ And can also add curd to melon pulp paste for a soft skin, it will nourish 
skin. 
¾ Take the watermelon seeds, grind them add to boiled hot water and mix it as 
a thick paste and apply as face masks. These melon seed's oil act as a good 
moisturizer for dry skin. 
¾ For sun burns, take watermelon, and cucumber in equal half, mix it and 
apply. 
¾  Watermelon has thirst quenching properties. Plus, it has anti-inflammatory, 
antioxidant, demulcent, vermifuge, febrifuge, purgative and mildly diuretic 
qualities. 
¾ Apart from the pink flesh, juicy watermelon rind also has several health 
benefits. For instance, it can heal  acne   breakouts and improve blood 
circulation. 
 ¾ Regular consumption of fresh juice extracted from this fruit, which is loaded 
with lycopene, protects against heart disease. 
¾ Moreover, studies have shown that higher levels of lycopene avoid damage 
caused by exposure to sunlight. Furthermore, watermelon works as a good 
hormone regulator. Plus, it strengthens  immunity and helps reduce the 
severity of asthma. 
¾ Watermelon aids   in weight  loss as well as it helps the metabolism work 
efficiently. It can prevent the formation of  kidney  stones, too. Intake of 
this amazing fruit benefits in soothing burning sensation caused by mouth 
sores and ulcers. 
¾ This fruit is also useful for healing   mild  erectile  dysfunction as it 
contains citrulline that helps relax blood vessels. Consuming this fruit can 
serve as a natural cure for increasing libido, too. 
¾ In addition, watermelon protects the eyes from age related macular 
degeneration, glaucoma and other similar ailments associated with the eyes. 
¾ It is good for brain and relieves symptoms of depression  and  nervous 
anxiety. Besides, it works as an efficient home remedy for bedwetting. 
¾ It is good for individuals suffering from osteoarthritis and rheumatism. 
¾ Eating this fruit on a daily basis during the summer season helps avoid heat 
stroke. Being rich in electrolytes, it prevents dehydration. 
 ¾ Consuming watermelon rind relieves heartburn and morning  sickness 
during pregnancy. It also reduces muscle cramps. 
¾ Boil a handful of watermelon seeds in water until the solution becomes thick. 
Drink this decoction on an empty stomach, first thing in the morning to get 
rid of intestinal worms. Follow this therapy for a few days. 
¾ Dry watermelon seeds under the sun for a day or two and boil two teaspoons 
of these seeds in a cup of water for about an hour. Cool and strain the 
solution. Drink this home medicine to reduce blood pressure. 
¾ Drinking watermelon seed tea can prove to be useful in dealing with urinary 
tract infection. 
¾ Having a glass of watermelon juice in the morning, on an empty stomach 
provides relief from headache. 
¾ Watermelon seed oil benefits in the natural treatment of rickets. 
¾ Consuming watermelon seed tea cleanses the kidney and bladder. To prepare 
this tea, pour two cups of hot water over a tablespoon of ground watermelon 
seeds. 
¾ Leave the solution for 15 minutes and then strain it. Drink this tea daily for 
about three days. This therapeutic tea also helps dissolve kidney stones. 
¾ Eating slices of watermelon mixed with a little black salt cures dry cough. 
¾ Simply eating this fruit for a few days relieves constipation. 
¾ Rubbing a piece of cold watermelon can heal skin sores. 
 ¾ Applying watermelon juice on skin for about 15 minutes helps avoid 
wrinkles as it tightens the skin. 
¾ Regularly using a combination of watermelon pulp and yogurt on skin serves 
as a natural remedy to exfoliate the skin and fade blemishes. And can also 
blend a mixture of watermelon, yogurt and banana, and apply it as a face 
mask for 15-20 minutes to get glowing skin. 
¾ To get  rid  of  blackheads and avoid sunburn, apply a combination of 
grated cucumber, watermelon juice, tomato juice and sufficient rice flour to 
form a paste. Wash it off after 10-15 minutes. 
¾ Roasted watermelon seeds can be eaten as snacks or sprinkled on salads. 
And can also make watermelon seed tea or include the seeds (ground) in 
soups to reduce the risk of developing cardiovascular  disease or type 2 
diabetes. 
¾ These seeds are high in protein and low in carbohydrates. Moreover, pickle 
or marinate the rind of this fruit after removing green part. 
Benefits of watermelon rinds 
 
 Nutritional Benefits 
A 1-inch cube of watermelon rind contains 1.8 calories. The majority of the 
calories come from carbohydrates, with 0.32 g per serving. While we will not derive 
a tremendous amount of macronutrients from eating watermelon rind, this food does 
contain some vitamins. One serving provides 2 percent of the daily recommended 
intake of vitamin C and 1 percent of the vitamin B-6 our body requires every day. 
This makes watermelon rind good for skin and immunity, as well as the health of 
nervous system. 
Economic Benefits 
Considered primarily a Southern food, pickles made from watermelon rind 
offer a tart taste and stretch food dollars. Homemade pickles made from watermelon 
rind offer an inexpensive alternative to purchased pickles. Because watermelon rind 
is often thrown out and not used, finding ways to use it for food, such as pickles, 
relishes or jam, extends the functionality of this fruit. And  cut the rind into spears 
and chunks, as well as shred it for recipes.  
Citrulline Content 
Watermelon rind contains a compound known as citrulline, according to a 
study published in the June 2005 issue of the "Journal of Chromatography." 
Citrulline might serve up a range of medicinal benefits. Evidence in the March 2011 
edition of the "Journal of the Science of Food and Agriculture" suggests that the 
citrulline in watermelon rinds gives it antioxidant effects that protect from free-
radical damage. Additionally, citrulline converts to arginine, an amino acid vital to 
the heart, circulatory system and immune system, say researchers from Texas A & 
 M's Fruit and Vegetable Improvement Center. These researchers speculate that 
watermelon rind might relax blood vessels and have a role in treating erectile 
dysfunction. 
Acne Treatment 
Acne, especially when it occurs on face, can be a humiliating medical 
condition, but using watermelon rind might help prevent breakouts. An article at the 
Complete Mother website notes that eating watermelon is key for treating acne, but 
can also rub watermelon rind on acne as a method of naturally clearing up face or 
other areas affected. 
Watermelon May Have Viagra-Effect 
“Arginine boosts nitric oxide, which relaxes blood vessels, the same basic 
effect that Viagra has, to treat erectile dysfunction and maybe even prevent 
it.”Citrulline, the precursor to arginine, is found in higher concentrations in the rind 
of watermelons than the flesh. 
Watermelon & the kidney 
Watermelon contains 92 percent water to hydrate body. One cup of raw 
watermelon contains 170 mg of potassium and only 2 mg of sodium. Potassium and 
sodium are minerals that help regulate blood pressure and fluid balance. Whereas 
sodium increases blood pressure, potassium can play a role in lowering blood 
pressure, according to an American Heart Association Nutrition Committee report 
published in "Circulation" in August 1998. Reducing blood pressure lowers risk of 
kidney disease. 
 Nitric Oxide 
Eating watermelon increases levels of nitric oxide and lowers risk of kidney 
disease (Traister, 2011). Watermelon, particularly the rind, is a rich source of 
citrulline, according to research from the United States Department of Agriculture in 
University, Missouri, and published in the "Journal of Chromatography A" in June 
2005. Citrulline is an amino acid that body converts to arginine, which is converted 
to nitric oxide. This gas increases blood flow and reduces blood pressure. A 
deficiency of nitric oxide is associated with an increased risk of chronic kidney 
disease, according to research from the University of Florida College of Medicine in 
Gainesville and published in the "American Journal of Physiology and Renal 
Physiology" in January 2008. The scientists report that nitric oxide deficiency occurs 
due to limitations in arginine availability. 
Lycopene 
Watermelon is a rich source of lycopene, an antioxidant that reduces 
oxidative stress in the kidneys. One cup of watermelon contains 6,889 mcg of 
lycopene. There have not been specific studies on lycopene from watermelon and 
the kidneys, but there has been research on the association between lycopene from 
tomatoes and kidney disease. Scientists at Firat University in Elazig, Turkey, found 
that lycopene has protective effects against kidney toxicity, according to research 
published in "Nutrition and Cancer" in April 2011. 
  
Eliminating Kidney Stones 
Watermelon is one of the best natural remedies for kidney stones available. It 
has the highest level of water among all types of fruit, and water is essential to being 
able to pass kidney stones. Watermelon is used as a diuretic, increasing the urine. 
What's more important, though, is watermelon's high level of potassium. 
This substance is a form of salt that actually helps to dissolve the kidney stones, 
therefore easing the pain and helping to eliminate them. This whole process can take 
up to 15 days but the difference, of course, can be felt much sooner than that. 
Preventing Kidney Stones 
Watermelon can also be used in preventative measures against kidney stones, 
especially for those who already have a history of kidney stones. If have a family 
history but haven't experienced stones yet, incorporate watermelon diet on a regular 
basis. 
Because there are no side effects with using this as a remedy or preventative 
measure, it can be consumed at any time unless have an allergy. 
Literature  survey 
¾ Swapnil Sharma et al., 2011 evaluated the laxative activity of Citrullus 
lanatus fruit pulp extract. It was observed, the fruit pulp aqueous extract of  
Citrullus lanatus produced significant and dose dependent increase in faeces 
output of rats and the stimulation of gastrointestinal motility. 
 ¾ Adesanya A et al., 2011 evaluated the effect of methanolic extract of  
Citrullus lanatus seed on experimentally induced prostatic hyperplasia. It was 
observed, treatment with extracts caused a significant decrease in the 
enlarged prostate, seminal vesicle and testes sizes in a dose related manner. 
¾ Munglue P et al., 2012 evaluated the effects of Citrullus lanatus flesh and 
rind extract and L-citrulline on rat uterine contractility. It was observed 
watermelon and citrulline are potent tocolytics, decreasing the force 
produced by calcium entry and SR release and arising by different pathways, 
including oxytocin stimulation. Their major mechanism is to stimulated the 
NO – cyclic guanosine monophosphate (cGMP) relaxant pathway. 
¾ Asghar MN et al., 2012 evaluated the effect of phytochemical and in vitro 
total antioxidant capacity analyses of peel extracts of different cultivars of 
Cucumis melo and Citrullus lanatus pulp and seeds. It was observed the 
potency of C.melo and C.lanatus extracts as antioxidant and radical 
scavenger plants which may be used as good sources of natural antioxidants. 
The peels of  both the plants can be added to the diet at various stages to 
compensate  
¾ Fernandez – Bayon JM et al., 1993 evaluated the physiological effects of 
ozone on cultivars watermelon (Citrullus lanatus) and muskmelon (Cucumis 
melo) widely grown in spain. It was observed, the exposure to ozone reduced 
flower production in both muskmelon and watermelon, which indicated 
effects on yield. 
 ¾ Olarewaju M.Oluba et al., 2008 evaluated the fatty acid composition of 
Citrullus lanatus (Egusi Melon) oil and its effect on serum lipids and some 
serum enzymes. It was observed, a corresponding significant reduction in 
serum activities of the  enzyme in the egusi melon oil – fed rats. In addition, 
feeding egusi melon oil (5% in the diet) to rats reduced severe 
atherosclerosis in the aorta. Histopathological examination showed that egusi 
melon oil reduced foam cell formation and inhibited smooth cell migration in 
the blood vessels of rats. 
¾ Okunrobo O.Lucky et al., 2012 evaluated the quantitative determination, 
metal analysis and antiulcer evaluation of methanol seeds extract of Citrullus 
lanatus Thunb (Cucurbitaceae) in rats. Proximate and metal content analysis 
of the seeds provided information that the consumption of the seeds of 
Citrullus lanatus was safe. This study also confirmed the exact mechanism 
underlying the ulcer healing and protecting property of the extract and to 
identify the chemical constituents responsible for it. 
¾ Naresh Singh Gill et al., 2011 evaluated the antioxidant and anti-ulcerative 
potential of Citrullus lanatus seed extract in rats. It was showed significant 
decrease in the gastric volume, free acidity and total acidity in case of pyloric 
ligated model and showed significant percentage inhibition of ulcer as 
indicated by decrease in ulcerative index.  
¾ Deng Jia-gang et al., 2010 evaluated the anti-inflammatory and analgesic 
effects of extract from roots and leaves of Citrullus lanatus. It was observed, 
the extract significantly inhibited the ear edema, granuloma hyperplasia and 
paw edema. The extracts could protect mice/rats from inflammation and 
 analgesia and may be safe as an orally administered natural product for 
human. 
¾ Hassan L E A et al., 2011 evaluated the In vitro antigiardial activity of 
Citrullus lanatus Var. citroides extracts and cucurbitacins isolated 
compounds. The results suggested that all the crude extracts and isolated 
compounds were against Giardia lamblia, hence C.lanatus var. citroides may 
be recommended as new source for the treatment of giardiasis. 
¾ Madhavi P et al., 2012 evaluated the Anti-Inflammatory Activity of 
Citrullus lanatus Seed Oil by In-vivo and In-vitro Models. The results 
showed significant reduction of edema in carrageenan induced rat paw 
edema model maximum at 3 hr. 
¾ Poduri A et al., 2013 evaluated the Citrullus lanatus ‘sentinel’ (watermelon) 
extract reduces atherosclerosis in LDL receptor-deficient mice. It was 
observed, the extract led to reduced body weight gain, decreased plasma 
cholesterol concentrations, improved homeostasis of pro- and anti-
inflammatory cytokines, and attenuated development of atherosclerosis 
without affecting systolic blood pressure in hypercholesterolemic mice. 
¾ Oyewo O. O et al., 2012 evaluated the effects of aqueous extract of Citrullus 
lanatus on the Histology of the Kidney of adult wistar rats. The results 
revealed that aqueous extract of Citrullus lanatus on the histology of the 
kidney in all the groups were normal when compared with the control 
groups. 
 ¾ Chidan Kumar CS et al., 2012 evaluated, Sugars extracted from 
watermelon (Citrullus lanatus) rind. The extracted sugars were put through 
some chemical characterization procedures for purposes of separation and 
identifying its components. The various standard sugars were spotted using 
the solvent system n-butanol - acetone - diethyl amine - water (10:10:2:6, 
v/v/v/v) in the cellulose layer for TLC analysis which indicated the presence 
of Rhamnose, sucrose, mannose and glucose. 
¾ Adi Kristanto T et al., 2013 evaluated the enhancement of fibroblast cell 
number due to oral administration of Watermelon (Citrullus lanatus) seeds 
extract in wound healing. The consumption of watermelon seed extract with 
100 % consentration can increase the amount of fibroblas in wound healing. 
¾ Hassan L E A et al., 2011 evaluated the In vitro antimicrobial activities   of 
chloroformic, hexane and ethanolic extracts of citrullus lanatus var. citroides. 
The ethanolic extract of the fruit pulp and stem showed the highest 
antifungal activity on Candida albican.  Aspergillus nigar was very sensitive 
to the chloroform extract of the seed and the ethanolic extract of the leaves .  
Based on the current findings, it can be concluded that this plant has 
antimicrobial activity, which is as potent as standard antimicrobial drugs 
against certain microorganisms. 
¾ Alok B et al., 2012 evaluated the anti-ulcer activity of Citrullus lanatus seed 
extract in wister albino rats. It was observed , Citrullus lanatus has 
significantly decreased the gastric volume (53.55%), free acidity (57.02%) 
and total acidity (36.53%) in case of pyloric ligation model. Conclusively the 
 ulcer protective effect of Citrullus lanatus may be due to its anti-secretory 
along with cytoprotective mechanism. 
¾ Raziq S et al., 2012 evaluated the characterization of seed oils from different 
varieties of watermelon [Citrullus lanatus (Thunb)] from Pakistan. The 
results indicated that the seeds of the tested watermelon varieties from 
Pakistan are a potential source of high-linoleic oil and thus can be explored 
for commercial use and value addition. 
¾ Asghar et al., 2013 evaluated the phytochemical and in vitro total 
antioxidant capacity analyses of peel extracts of different cultivars 
of Cucumis melo and Citrullus lanatus. Employing GC-MS analyses and 
standard in vitro antioxidative assays, the data presented that the potency 
of C. melo and C. lanatus extracts as antioxidant and radical scavenger plants 
which may be used as good sources of natural antioxidants. The peels of both 
the plants can be added to the diet at various stages to compensate food 
shortage and dietary deficiency problems of living beings. 
¾ Johnson J.T. et al., 2012 evaluated the anti-nutrient contents of watermelon 
Citrullus lanatus pulp, seeds and rinds. The study was carried out on both 
fresh and dried samples. Results of the investigation revealed that the anti-
nutritional components such assaponin, alkaloid, hydrocyanic acid, phenols, 
oxalate, tannins, phytates were detected in all the samples but at a varying 
tolerable concentration. 
¾ Besler M et al., 2001 presented Allergen Data Collection of Watermelon 
(Citrullus lanatus). The data informed the symptoms of allergy to 
 watermelon as well as diagnostic features, and the occurrence of cross-
reacting allergens. 
 
 
 
 
 
 
 
 
 
 
 
 
  
Aim and Objectives 
AIM AND OBJECTIVE 
Acute renal failure (ARF) is a clinical syndrome characterized by rapid 
deterioration of renal function, which is faced in many clinical situations. ARF is 
classically divided into pre-renal, renal (intrinsic) and post-renal failure. Pre-renal 
AFR is a consequence of decrease in renal perfusion (due to hypovolemia/shock or 
ischemia), which leads to reduction in GFR. Intrinsic renal failure occurs when there 
is damage to the structures of nephron such as glomeruli, tubules, vessels or 
interstitium. The major cause of intrinsic ARF is acute tubular necrosis (ATN) that 
results from ischemia or neprotoxic injury. Pre-renal ARF and ischemic ATN may 
occur as continuation of the same pathophysiological process, and together account 
for 75 % of the causes of ARF. Post-renal ARF follows obstruction of the urinary 
collection system with an increase in pressure within the renal collecting systems 
resulting in reduced GFR and renal failure.  
 ARF following ischemia/reperfusion (I/R) is major complication after renal 
transplantation, renal surgery including partial nephrectomy, renal artery 
angioplasty, aneurysm surgery, elective urological operations and clinical conditions 
associated with renal perfusion. The mortality rate of patients with ARF has 
remained 25-70 % despite the use of various pharmacological agents. Therefore, it 
continues to be a frequent threatening complication following trauma, complex 
surgical procedures, and in patients hospitalized in intensive care units. In the 
 absence of reliable and effective modern therapy for ARF, concerted efforts are 
currently challenged towards exploring alternative therapy in the disease treatment 
and/or prevention. Recently, plant products have been of great interest for their 
potential uses as alternative remedies for the treatment of many diseases. Ancient 
literature has prescribed various herbs for treatment of kidney diseases and certain 
Indian medicinal plants have been reported to exhibit protective effect on renal 
tissues against injuries.      
Citrullus lanatus (Watermelon) belongs to family Cucurbitaceae originally 
from South Africa, is widely distributed in Africa and Asia. The growth is favoured 
in dry climate and is mainly a dry season crop in monsoon areas, requiring only 
limited rainfall. It is an annual herb with long stems lying or creeping on the ground, 
with curly tendrils. Fruits vary considerably in size range from about 7 cm in 
diameter to over 20 cm. The flesh amounts to about 65 % of the whole fruit, and of 
this 95 % is water. Fruit is good source of vitamin A, vitamin B, vitamin C and 
potassium which are essential for maintenance of human health. The seeds are used 
as vermifuge and possess antimicrobial property. It is also used in treatment of 
prostatic hyperplasia and possesses anti-oxidant, anti-inflammatory and analgesic 
properties. The juice squeezed from pulp is used as anthelmintic and diuretic. The 
other ethno-medicinal uses of fruit include purgative, remedy for urinary stones, 
gonorrhoea and leucorrhoea in women, anti-ulcerative. The fruit is rich in lycopene, 
an antioxidant carotenoid effective against certain types of cancer and 
cardiovascular diseases.  
 The rind of fruit is rich source of aminoacid citrulline, a precursor of L-
arginine, the substrate for nitric oxide synthase in the production of nitric oxide 
 (NO). NO activates soluble guanylate cyclase leading to an increased conversion of 
GTP to cGMP, which provides the signal for smooth muscle relaxation, including 
corpus cavernosum of penis and myocardium. Recent work has shown that 
watermelon consumption increased plasma arginine levels which improved aortic 
haemodynamics. Citrulline in watermelon rind also possessed anti-oxidant property 
against free radical damage. Based on the reports of several studies on vascular 
smooth muscle relaxant effect of watermelon rind, a study was planned to evaluate 
the renoprotective effect of watermelon rind on ischemia/reperfusion induced acute 
renal damage in albino wistar rats.   
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Plan of work 
PLAN OF WORK 
Plan of work is 
¾ To collect watermelon (Citrullus lanatus) rinds, to shade dry and powder 
dried rind. 
¾ To extract dried rind powder using methanol in soxhlet apparatus for 72 
hours. 
¾ To analyse the phytoconstituents present in Citrullus lanatus rind extract. 
¾ To evaluate the acute oral toxicity study of Citrullus lanatus extract. 
Pharmacological Screening 
¾ To evaluate relaxant effect of Citrullus lanatus rind extract on rat thoracic 
aorta rings (Invitro). 
¾ To evaluate renoprotective activity of Citrullus lanatus rind extract on 
Ischemia/Reperfusion – Induced Renal Damage in rat by assessing renal 
function 
1) By biochemical investigation of renal parameters. 
2) By measuring lipid peroxidation and anti-oxidant enzyme activities in 
kidney. 
3) By histopathological examination of kidney tissue. 
 Statistical analysis 
¾ Evaluation of results obtained by One way ANOVA followed by standard 
Dunnet’s test. 
 
 
 
 
 
 
 
 
 
 
 
 
  
Materials and methods 
MATERIALS AND METHODS 
Plant material 
The fresh rind of Citrullus lanatus fruits were collected from local market at 
komarapalayam, Tamilnadu. The collected rind of Citrullus lanatus fruits were 
shade dried and the dried materials were crushed to coarse powder with mechanical 
grinder. The powder was stored in air tight container for extraction. 
Extraction  
About 57.26 gm of dried powder were subjected to extraction with methanol 
using soxhlet apparatus for 72 hours. After completion of extraction, methanol was 
removed by distillation. The residue obtained was air dried. The dried methanol 
extract was stored in air tight glass container for further investigation. 
 Phytochemical screening 
The extract obtained was subjected to preliminary phytochemical screening 
(Tiwari et al., 2011). 
Qualitative tests: 
1. Detection of alkaloids:  
Extracts were dissolved individually in dilute Hydrochloric acid and filtered. 
  
a) Mayer’s Test: 
Filtrates were treated with Mayer’s reagent (Potassium Mercuric Iodide). 
Formation of a yellow coloured precipitate indicates the presence of alkaloids. 
b) Wagner’s Test: 
Filtrates were treated with Wagner’s reagent (Iodine in Potassium Iodide). 
Formation  of brown/reddish precipitate indicates the presence of alkaloids. 
c) Dragendroff’s Test:  
Filtrates were treated with Dragendroff’s reagent (solution of Potassium 
Bismuth Iodide). Formation of red precipitate indicates the presence of alkaloids.  
d) Hager’s Test: 
Filtrates were treated with Hager’s reagent (saturated picric acid solution). 
Presence of alkaloids confirmed by the formation of yellow coloured precipitate.  
 2. Detection of carbohydrates:  
Extracts were dissolved individually in 5 ml distilled water and filtered. The 
filtrates were used to test for the presence of carbohydrates.  
a) Molisch’s Test: 
Filtrates were treated with 2 drops of alcoholic α-naphthol solution in a test 
tube. Formation of the violet ring at the junction indicates the presence of 
Carbohydrates.  
 b) Benedict’s Test: 
Filtrates were treated with Benedict’s reagent and heated gently. Orange red 
precipitate indicates the presence of reducing sugars.  
c)  Fehling’s Test:  
Filtrates were hydrolysed with dil. HCl, neutralized with alkali and heated 
with Fehling’s A & B solutions. Formation of red precipitate indicates the presence 
of reducing sugars.  
3. Detection of glycosides:  
Extracts were hydrolysed with dil. HCl, and then subjected to test for 
glycosides.  
a) Modified Borntrager’s Test: 
Extracts were treated with Ferric Chloride solution and immersed in boiling 
water for about 5 minutes. The mixture was cooled and extracted with equal 
volumes of benzene. The benzene layer was separated and treated with ammonia 
solution. Formation of rose-pink colour in the ammonical layer indicates the 
presence of anthranol glycosides.  
 4. Legal’s Test:  
Extracts were treated with sodium nitropruside in pyridine and sodium 
hydroxide. Formation of pink to blood red colour indicates the presence of cardiac 
glycosides. 
5. Detection of saponins  
 a) Froth Test:  
Extracts were diluted with distilled water to 20ml and this was shaken in a 
graduated cylinder for 15 minutes. Formation of 1 cm layer of foam indicates the 
presence of saponins. 
b) Foam Test: 
0.5 gm of extract was shaken with 2 ml of water. If foam produced persists 
for ten minutes it indicates the presence of saponins.  
 6. Detection of phytosterols  
a) Salkowski’s Test:  
Extracts were treated with chloroform and filtered. The filtrates were treated 
with few drops of Conc. Sulphuric acid, shaken and allowed to stand. Appearance of 
golden yellow colour indicates the presence of triterpenes. 
b) Libermann Burchard’s test: 
Extracts were treated with chloroform and filtered. The filtrates were treated 
with few drops of acetic anhydride, boiled and cooled. Conc. Sulphuric acid was 
added. Formation of  brown ring at the junction indicates the presence of 
phytosterols.  
  
7. Detection of phenols  
Ferric Chloride Test:  
Extracts were treated with 3-4 drops of ferric chloride solution. Formation of 
bluish black colour indicates the presence of phenols.  
8. Detection of tannins  
Gelatin Test:  
To the extract, 1% gelatin solution containing sodium chloride was added. 
Formation of white precipitate indicates the presence of tannins.  
9. Detection of flavonoids  
a) Alkaline Reagent Test:  
Extracts were treated with few drops of sodium hydroxide solution. 
Formation of intense yellow colour, which becomes colourless on addition of dilute 
acid, indicates the presence of flavonoids.  
b) Lead acetate Test:  
Extracts were treated with few drops of lead acetate solution. Formation of 
yellow colour precipitate indicates the presence of flavonoids.  
  
10. Detection of proteins and aminoacids  
a) Xanthoproteic Test:  
The extracts were treated with few drops of conc. Nitric acid. Formation                           
of yellow colour indicates the presence of proteins.   
 b) Ninhydrin Test:  
To the extract, 0.25% w/v ninhydrin reagent was added and boiled for few 
minutes. Formation of blue colour indicates the presence of amino acid. 
11. Detection of diterpenes  
Copper acetate Test:  
Extracts were dissolved in water and treated with 3-4 drops of copper acetate 
solution. Formation of emerald green colour indicates the presence of diterpenes. 
Acute oral  toxicity  study  of  methanol extract  of  Citrullus lanatus.  rinds 
Animals:  
Swiss albino mice of female sex weighing 20-25 gms were used for the 
study. The animals were housed in polypropylene cages. The animals were 
maintained under standard laboratory conditions (25º ± 2ºC; 12hr light and dark 
cycle). The animals were fed with standard diet and water ad libitum. Ethical 
clearance (for handling of animals and the procedures used in study) was obtained 
from the Institutional Animal Ethical Committee before performing the study on 
animals. 
 Acute Toxicity Test: 
Acute oral toxicity study for methanol extract of Citrullus lanatus rinds was 
carried out as per OECD guideline 425 (Up and Down procedure). The test 
procedure minimizes the number of animals required to estimate the acute oral 
toxicity. The test allows the observation of signs of toxicity and can also be used to 
identify chemicals that are likely to have low toxicity. 
Animals were fasted (food but not water was with held overnight) prior to 
dosing. The fasted body weight of each animal was determined and the dose was 
calculated according to the body weight. 
Limit Test at 2000 mg/kg 
The drug was administered in the dose of 2000 mg/kg body weight orally to 
one animal. If the test animal survived, then four animals were dosed sequentially; 
therefore, a total of five animals were tested. Animals were observed individually at 
least once during the first 30 minutes after dosing., periodically during the first 24 
hours (with special attention given during the first 4 hour), and daily thereafter, for a 
total of 14 days. After the experimental period, the animals were weighed and 
humanely killed and their vital organs including heart, lungs, liver, kidneys, spleen, 
adrenals, sex organs and brain were grossly examined.  
  
Evaluation of Citrullus lanatus rind extract on vascular response in pre-
contracted rat thoracic aortic rings 
Preparation of rat thoracic aortic rings and experimental protocol 
Rats were anesthetized with pentobarbitone sodium (60 mg/kg body weight, 
ip) and subsequently bled and exsanguinated. A midline incision was made through 
the sternum to expose the thoracic aorta. The aorta was carefully isolated, freed from 
surrounding fat and adherent connective tissue and cut into 3-5 mm long rings. The 
rings were suspended horizontally in tissue chambers containing kreb’s 
physiological solution. Special care was taken to avoid damage to the endothelium. 
The tissue bath solution was constantly bubbled with a mixture of 95% O2 and 5% 
CO2 (carbogen) at 37°C. All aortic rings were allowed to equilibrate under a resting 
tension of 500 mg for 30 min. During this period, kreb’s physiological solution was 
replaced every 15 min to protect against interfering metabolites (Altura, et al., 1970 
and Guedes, et al., 2004). 
After stabilization, the effect of Citrullus lanatus rind extract on response of 
phenyeprine in rat thoracic aortic rings was recorded. 
Evaluation of renoprotective activity of Citrullus lanatus rind extract on 
Ischemia/Reperfusion – Induced Renal Damage in rat by assessing renal 
function 
Healthy, young adult albino wistar rats (150 – 200 gms) were used for the 
study. The animals were obtained from Agricultural University, Mannuthy, Thrissur, 
Kerala (328/99/CPCSEA) and were housed in polypropylene cages. The animals 
 were maintained under standard laboratory conditions (25˚ ± 2˚C; 12 hours light and 
dark cycle). The animals were fed with standard diet and water ad libitum. Ethical 
clearance (for handling of animals and the procedures used in study) was obtained 
from the Institutional Animal Ethical Committee (887/ac/05/CPCSEA) before 
performing the study on animals. 
Twenty four albino rats were divided into four groups of six animals each. 
First group served as normal received 0.5% carboxy methyl cellulose 2 ml/kg for 6 
days. Second group served as (Ischemia/Reperfusion induced Renal damage) 
untreated group received 0.5% carboxy methyl cellulose 2ml/kg for 6 days. Third 
group served as treatment group received, methanolic rind extract of Citrullus 
lanatus 200 mg/kg for 6 days. Fourth group served as treatment group received 
methanolic rind extract of Citrullus lanatus 400 mg/kg for 6 days. On seventh day, 
the rats in all groups were anesthetized by intraperitoneal injection of ketamine 100 
mg/kg and xylazine 10 mg/kg. Both renal pedicles were identified through a midline 
incision and occluded with a renal pedicle occlusion clamp for 60minutes. The 
clamps were then removed and reperfusion of the kidneys was allowed. Afterwards, 
the abdomen was closed with continuous sutures in 2 layers.  All of the rats were 
sacrificed after 6 hours of reperfusion period and both kidneys were harvested for 
antioxidant and histological analyses. 
Kidney Function Study 
Blood was collected from the rats by retro-orbital puncture at the time of 
sacrify and was allowed to clot for 10 minutes at room temperature. Clots were 
centrifuged at 2500 rpm for 10 minutes to separate the serum. Serum creatinine, 
urea, and uric acid levels were analysed. 
 Preparation of Tissue Homogenates 
After sacrificing the animals, their kidneys were quickly removed, perfused 
immediately with ice cold hypertonic saline solution, and homogenized in chilled 
potassium chloride (1.17 %) using a Potter Elvehjem homogenizer (Remi, Mumbai, 
India). The homogenate was centrifuged at 10500 g for 20 minutes at 4°C to get the 
postmitochondrial supernatant, which was used to assay superoxide dismutage, 
catalase, reduced glutathione, and lipid peroxidation activity. 
Estimation of Antioxidant Enzymes 
Estimation of Lipid peroxidation (LPO) 
By the method described by Ohkawa et al, the levels of thiobarbituric acid 
reactive substances in the kidney was measured (Ohkawa and Ohishi et al., 1979). 
The portion of kidney homogenates was mixed with 0.2 ml of 8.1% Sodium dodecyl 
sulphate, 1.5 ml of 20% acetic acid and 1.5 mL of 0.8% thiobarbituric acid, then the 
volume was adjusted to 4.0 ml with distilled water. With 1.0 ml of distilled water 
and 5.0 ml of n- butanol and pyridine (15:1 v/v) the reaction mixture was extracted 
and the absorbance was measured in organic layer at 532 nm after centrifugation.  
Estimation of superoxide dismutase (SOD) activity 
After diluting the 0.5 ml of tissue homogenate with water, 2.5 ml of ethanol 
and 1.5 ml of chloroform were added and mixed for 1 min at 4 °C and centrifuged. 
The supernatant was separated and determined for enzyme activity. Appropriately 
diluted enzyme preparation is mixed with 1.2 ml of sodium pyrophosphate buffer 
(0.025 M, pH 8.3), 0.1 ml of 186 μM PMS, 0.3ml of 30 μM Nitroblue tetrazolium 
(NBT), 0.2 ml of 780 μM NADH, and water in a total volume of 3 ml. By addition 
 addition of  NADH, the reaction was started. After the reaction, by the addition of 1 
ml glacial acetic acid and incubation at 30°C for 90 seconds, the reaction was 
stopped. With 4 ml of n-butanol, the reaction mixture was stirred vigorously and 
shaken. At 560 nm, the intensity of the chromogen was measured in the butanol 
layer against butanol blank. A system devoid of enzyme served as control (Kakkar et 
al., 1984) 
Estimation of catalase activity 
0.1 ml of tissue homogenate is mixed with 1.0 ml of 0.01M phosphate buffer 
(pH 7.0), and 0.4 ml of 2M H2O2. By the addition of 2.0 ml of dichromate-acetic 
acid reagent the reaction was stopped (5% potassium dichromate and glacial acetic 
acid were mixed in 1:3 ratio).  The absorbance was measured at 620 nm. Catalase 
activity was expressed as nM of H2O2 consumed/min/mg protein (Sinha, 1972). 
Reduced Glutathione (GSH) activity  
Reduced glutathione was estimated by the method of Ellman (1959). 0.5 ml 
of tissue homogenate was precipitated with 2 ml of 5 % TCA. After centrifugation, 1 
ml of supernatant was taken and added 0.5 ml of Ellman’s reagent (19.8 mg of 5,5’ 
dithio (bis) nitrobenzoic acid in 100 ml of 1% sodium citrate) and 3 ml of phosphate 
buffer. Standards were treated in a similar way and the colour developed was read at 
412nm. 
  
Histological Analysis 
The kidneys fixed in a 10% neutral-buffered formalin solution were 
embedded in paraffin and were used for histopathological examination. Five 
micrometer- thick sections were cut, deparaffinized, hydrated, and stained with 
hematoxylin-eosin. The renal sections were examined blindly for tubular cell 
swelling, interstitial edema, tubular dilatation, and moderate to severe necrosis in all 
groups.  
Statistical Analyses 
Results were expressed as mean ± standard error of mean (S.E.M). The 
results were analysed for statistical significance by one way ANOVA followed by 
dunnett’s test (Graphpad software Inc, La Jolla, CA. Trial version). The criterior for 
statistical significance was set at P<0.05. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 Results and Discussion 
RESULTS AND DISCUSSION 
Extraction yield 
Watermelon rind powder used for extraction - 57.26 gm 
Solvent used for extraction- 1000 ml 
Extraction yield obtained using methanol as solvent – 30.70 % w/w 
Table. 3 Phytoconstituents detected in methanol extract of Citrullus lanatus rind 
Phytochemicals Test Methanoll 
extract 
Alkaloids  a.  Mayer’s test 
b.  Dragendroff’s 
c.  Hager’s test 
d.  Wagner’s test 
+ 
+ 
+ 
+ 
Phytosterols  a.  Leiberman Burchard 
b.  Salkowaski test 
+ 
+ 
Flavonoids 
 
a. Alkaline reagent test 
b .Lead acetate test 
+ 
+ 
Saponins 
 
a. Froth test 
b. Foam test 
+ 
+ 
Proteins 
and Aminoacids 
a.  Xanthoproteic test 
b.  Ninhydrin test 
+ 
+ 
 
Diterpenes 
 
a. Copper acetate test + 
 
Phenolics and Tannins
 
a.  Ferric chloride test 
b.  Gelatin test 
 
‐ 
‐ 
 
Carbohydrate 
 
a.  Molisch’s test 
b.  Fehling’s test 
c.  Benedict’s test 
 
‐ 
+ 
+ 
 
Gylcosides 
 
a.  Modified          Borntrager’s test
b.  Legal’s test 
‐ 
‐ 
(+ Present ; - Absent) 
  
Table. 4 : Acute oral Toxicity study of methanolic extract of  
Citrullus lanatus rind. (Guideline 425) 
RESPIRATORY BLOCKAGE IN NOSTRIL  
Dyspnoea Nil 
Apnoea Nil 
Tachypnea Nil 
Nostril discharge Nil 
MOTOR ACTIVITIES 
Locomotion Normal 
Somnolence Nil 
Loss of righting reflex Nil 
Anaesthesia Nil 
Catalepsy Nil 
Ataxia Nil 
Toe walking Nil 
Prostration Nil 
Fasciculation Nil 
Tremor Nil 
CONVULSION (INVOLUNTRAY CONTRACTION) 
Clonic/tonic/tonic-clonic convulsion Nil 
Asphyxial convulsion Nil 
Opistotones (titanic spasm) Nil 
REFLEXES 
Corneal Normal 
 Eyelid closure Normal 
Righting Normal 
Light Normal 
Auditory and sensory Normal 
OCULAR SIGNS 
Lacrimation Nil 
Miosis Nil 
Mydriasis Nil 
Ptosis Nil 
Chromodacryorrhea Nil 
Iritis Nil 
Conjunctivitis Nil 
SALIVATION  
Saliva secretion Nil 
PILOERECTION   
Contraction of erectile tissue Nil 
ANALGESIA  
Decrease in reaction to induced pain Nil 
MUSCLE TONE  
Hypo or hypertonia Nil 
GIT SIGN  
Solid  dried / watery stool Nil 
Emesis Nil 
Red urine Nil 
SKIN  
 Oedema  Nil 
 
Figure No. 5 : Evaluation of Citrullus lanatus rind extract on vascular response in 
pre-contracted rat thoracic aortic rings 
 
The effect of Citrullus lanatus rind extract on aortic rings on response of 
phenylephrine was studied. Phenylephrine by acting on α1 receptor produced 
contraction of aortic rings. A contraction of 40 µg was used to contract aortic rings. 
Methanol extract of Citrullus lanatus rind extract at concentration of 100 µg blocked 
the effect of phenylephrine. This might be due to vasorelaxant effect of Citrullus 
lanatus rind extract through α1 receptor blockade activity, mediated through 
endothelium – derived relaxant factors.  
  
Figure No. 6 Renal pedicle occlusion 
 
                         Normal                                                   I/R injury 
untreated                      
 
   I/R injury + Extract 200 mg/kg                       I/R injury + Extract 400 mg/kg 
                      
 
Table. 5 : Effect of Citrullus lanatus rind extract on serum urea, uric acid and 
creatinine in rats exposed to renal ischemia reperfusion( I/R) injury 
Group Treatment Urea 
(mg/dl) 
Uric acid 
(mg/dl) 
Creatinine 
(mg/dl) 
Group I 
normal 
0.5% CMC 
(2 ml/kg) 
80.59 ± 5.91 1.75 ± 0.05 1.41 ± 0.03 
Group  II 
I/R injury 
untreated 
0.5% CMC 
(2 ml/kg) 
 
139.1±2.55*** 
a 
2.71 ± 0.07*** 
a 
2.77 ± 0.09*** 
Group III 
Treated 
MECL 
(200mg/kg) 
b 
129.7 ± 1.37ns 
b 
2.15 ± 0.08** 
b 
2.70 ± 0.04ns 
Group IV 
Treated 
MECL 
(400mg/kg) 
b
110.4 ±2.31*** 
b 
1.73 ± 0.10*** 
b 
2.08 ± 0.02*** 
 
All values are expressed as mean ± S.E.M, n=6 in each group. One way ANOVA 
followed by Dunnett’s test was used to compare experimental groups. 
a Values are significantly different from control group; ns-non significant; *P<0.05; 
**P<0.01; ***P<0.001. 
b Values are significantly different from I/R injury untreated group; ns-non significant; 
*P<0.05; **P<0.01; ***P<0.001. 
  
Effect of Citrullus lanatus rind extract on serum urea, uric acid and creatinine in 
rats exposed to renal ischemia reperfusion( I/R) injury 
Figure No. 7 
 
 
 Effect of Citrullus lanatus rind extract on serum urea, uric acid and creatinine 
in control and experimental rats exposed to Ischemia/Reperfusion induced kidney 
damage. Results are expressed as mean ± S.E.M, n=6 in each group. One way 
ANOVA followed by Dunnett’s test was used to compare experimental groups. 
aValues are significantly different from control group; ns-non significant; *P<0.05; 
**P<0.01; ***P<0.001. bValues are significantly different from I/R injury untreated 
group; ns-non significant; *P<0.05; **P<0.01; ***P<0.001. Significant increase in 
activites of urea (***P<0.001), uricacid (***P<0.001), creatinine (***P<0.001) were 
noted in Ischemia/Reperfusion induced untreated animals compared to normal 
animals. Ischemia/Reperfusion induced animals treated with extract (I/R injury + 
Extract 200 mg/kg and I/R injury + Extract 400 mg/kg) showed a significant decrease 
in activities of urea (200 mg/kg-  nsnon significant, 400 mg/kg- ***P<0.001), uricacid 
(200 mg/kg- **P<0.01, 400 mg/kg- ***P<0.001) and creatinine (200 mg/kg- nsnon 
significant , 400 mg/kg- ***P<0.001) compared to I/R injury untreated animals. 
 
 
 
 
 
 
 
 
 Effect of Citrullus lanatus rind extract on lipid peroxidation and antioxidants in 
rats exposed to renal ischemia reperfusion (I/R) injury 
Table. 6 
 
All values are expressed as mean ± S.E.M, n=6 in each group. One way ANOVA 
followed by Dunnett’s test was used to compare experimental groups. 
a Values are significantly different from control group; ns-non significant; *P<0.05; 
**P<0.01; ***P<0.001. 
                      b Values are significantly different from I/R injury untreated group; ns-non 
significant; *P<0.05; **P<0.01; ***P<0.001. 
Group Treatment 
LPO 
(MDA nmole/ 
hr/ gm of 
tissue) 
SOD 
(U/mg of 
protein) 
CAT 
(Nmole of H2O2 
consumed/ min/ 
of protein) 
GSH 
(µmole of 
NADPH 
oxidized/ min 
mg protein) 
Group I 
normal 
0.5% CMC 
(2 ml/kg) 
 
0.68 ± 0.04 
 
1.71 ± 0.04 
 
1.38 ± 0.07 
 
1.28 ± 0.04 
Group  II 
I/R injury 
untreated 
0.5% CMC 
(2 ml/kg) 
 
                                   s a 
1.6 ± 0.12*** 
                                   a 
0.88 ± 0.07*** 
 
                                   a 
0.70 ± 0.06*** 
                                      a 
0.76 ± 0.05*** 
Group III 
Treated 
MECL 
(200mg/kg) 
                                     b 
0.86 ± 0.07*** 
                            b 
1.23 ± 0.09ns 
                                     b 
1.33 ± 0.09*** 
                                 b 
1.01 ± 0.04* 
Group IV 
Treated 
MECL 
(400mg/kg) 
                                    b 
0.71 ± 0.06*** 
                              b 
1.40 ± 0.09** 
                                     b 
1.46 ± 0.06*** 
                                     b 
1.15 ± 0.05*** 
  
Effect of Citrullus lanatus rind extract on lipid peroxidation and antioxidants in 
rats exposed to renal ischemia reperfusion (I/R) injury 
Figure No. 8 
 
Effect of Citrullus lanatus rind extract on lipid peroxidation in kidney 
homogenate of control and experimental animals during Ischemia/Reperfusion 
induced kidney damage. Results are expressed as mean ± S.E.M, n=6 in each group. 
 One way ANOVA followed by Dunnett’s test was used to compare experimental 
groups. a Values are significantly different from control group; ns-non significant; 
*P<0.05; **P<0.01; ***P<0.001. b Values are significantly different from I/R injury 
untreated group; ns-non significant; *P<0.05; **P<0.01; ***P<0.001. Significant 
increase (***P <0.001) in lipid peroxidation were noted in Ischemia/Reperfusion 
induced untreated animals compared to normal animals. Ischemia/Reperfusion 
induced animals treated with extract (I/R injury + Extract 200 mg/kg and I/R injury + 
Extract 400 mg/kg) showed a significant decrease in lipid peroxidation levels (200 
mg/kg- ***P<0.001, 400 mg/kg- ***P <0.001) compared to Ischemia Reperfusion 
injury untreated animals. 
Effect of Citrullus lanatus rind extract on the status of antioxidants in kidney 
homogenate of control and experimental animals during Ischemia/Reperfusion 
induced kidney damage. Results are expressed as mean ± S.E.M, n=6 in each group. 
One way ANOVA followed by Dunnett’s test was used to compare experimental 
groups. a Values are significantly different from control group; ns-non significant; 
*P<0.05; **P<0.01; ***P<0.001. b Values are significantly different from I/R injury 
untreated group; ns-non significant; *P<0.05; **P<0.01; ***P<0.001. Significant 
decrease in activites of SOD (***P<0.001), catalase (***P<0.001), GSH (***P<0.001)  
were noted in Ischemia/Reperfusion induced untreated animals compared to normal 
animals. Ischemia/Reperfusion induced animals treated with extract (I/R injury + 
Extract 200 mg/kg and I/R injury + Extract 400 mg/kg) showed a significant increase 
in activities of SOD (200 mg/kg-  nsnon significant, 400 mg/kg- **P<0.01), catalase 
(200 mg/kg- ***P<0.001, 400 mg/kg- ***P<0.001) and GSH (200 mg/kg- *P<0.05, 400 
mg/kg- ***P<0.001) compared to I/R injury untreated animals. 
  
HISTOPATHOLICAL IMAGE OF KIDNEY 
NORMAL 
   Figure No. 9 
       
    Normal cortex and medulla (10 X)                     Normal interstitium (10 X)  
       
              Normal glomeruli  (40 X)                        Normal glomeruli (40 X)  
  
I/R INJURY UNTREATED 
Figure No. 10 
        
          Nerosis with edema (10 X)                     Large areas of hemorrhage (10 X) 
         
  Glomeruli shows loss of shape (40 X)          Glomeruli shows loss of shape (40 X) 
 
 
 
 
 
 
 I/R INJURY UNTREATED 
             
         Shows dilated tubules (40 X)               Glomeruli damage, congested tubules  
                                                                          with eosinophilic material (40 X) 
       
    Damaged glomeruli with congested  
                     tubules (40 X)                                  Shedding of epithelium (40 X) 
 
 
 
 
 
 I/R INJURY + EXTRACT 200 mg/kg 
Figure No. 11 
         
          Edema with necrosis (10 X)           Glomeruli with loss of shape, necrosis (10 X) 
         
           Glomeruli with loss of shape                   Edema with necrosis (40 X) 
                and architecture (40 X) 
  
I/R INJURY + EXTRACT 400 mg/kg 
Figure No. 12 
         
     Normal glomeruli and eosinophilic                       Normal glomeruli (40 X) 
           material in the tubules (10 X)  
        
      Interstitium appear normal (40 X)                         Normal PCT and DCT 
  
Percentage yield  
The percentage yield of extract obtained from extraction of powdered rind 
material of Citrullus lanatus using methanol as solvent was found to be 30.70 % w/w. 
Phytochemical study 
The phytochemical examination of methanol extract of Citrullus lanatus rind 
revealed the presence of carbohydrates, alkaloids, phytosterols, flavonoids, saponins, 
aminoacids, diterpenes, phenolics and tannins (Table 3).  
Acute oral toxicity study of methanol extract of Citrullus lanatus rind 
Acute oral toxicity study was carried out as per OECD guideline 425. From the 
limit test results, it was observed that the methanol extract of Citrullus lanatus rind 
was safe upto a dose level of 2000 mg/kg. There was no mortality and the 
experimental animals did not show any toxic effect throughout the observation period 
of 14 days (Table 4).  
Effect of methanol extract of Citrullus lanatus rind on serum urea, uric acid and 
creatinine levels in rats exposed to renal ischemia reperfusion (I/R) injury  
Rats in group II disease control exposed to renal ischemia reperfusion (I/R) 
injury for 60 minutes showed a significant increase (p<0.001) in serum urea (139.1 ± 
2.55), uric acid (2.71 ± 0.07) and creatinine (2.77 ± 0.09) levels compared to group I 
control animals with serum urea (80.59 ± 5.91), uric acid (1.75 ± 0.05) and creatinine 
levels (1.41 ± 0.003). Animals in group III treated with methanol extract of Citrullus 
lanatus rind 200 mg/kg for 6 days prior to  renal ischemia reperfusion (I/R) injury 
 showed a significant decrease (p<0.01) in uric acid levels (2.15 ± 0.08) compared to 
disease control animals. Whereas serum urea and serum creatinine levels in animals 
treated with methanol extract of Citrullus lanatus rind 200 mg/kg were statistically 
non-significant (ns) compared to untreated animals. Group IV animals treated with 
methanol extract of Citrullus lanatus rind 400 mg/kg for 6 days prior to  renal 
ischemia reperfusion (I/R) injury showed a significant decrease (p<0.001) in serum 
urea (110.4 ± 2.31), uric acid (1.73 ± 0.10) and creatinine levels (2.08 ± 0.02) 
compared to disease control animals (Table 5).  
Effect of methanol extract of Citrullus lanatus rind on lipid peroxidation in rats 
exposed to renal ischemia reperfusion (I/R) injury 
The levels of lipid peroxidation in kidney of control and experimental animals 
are illustrated in table 6. A significant increase (p<0.001) in production of 
malondialdehyde  (MDA) (1.6 ± 0.12) was observed in group II disease control 
animals exposed to renal ischemia reperfusion (I/R) injury for 60 minutes compared to 
MDA levels in kidney of group I control animals. Administration of methanol extract 
of Citrullus lanatus rind to group III and group IV animals at dose levels of 200 
mg/kg and 400 mg/kg respectively for 6 days prior to renal ischemia reperfusion (I/R) 
injury significantly decreased the MDA levels. The MDA levels were 0.86 ± 0.07 
nmole/hr/gm of tissue in animals treated with 200 mg/kg extract and 0.71 ± 0.06 
nmole/hr/gm of tissue in animals treated with 400 mg/kg. 
Effect of methanol extract of Citrullus lanatus rind on antioxidant status in rats 
exposed to renal ischemia reperfusion (I/R) injury 
  Table 6 illustrates the effect of methanol extract of Citrullus lanatus rind on 
antioxidant status in kidney of control and experimental animals. A significant 
decrease (p<0.001) in superoxide dismutase (SOD) (0.88 ± 0.07), catalase (CAT) (0.70 
± 0.06) and reduced glutathione (GSH) (0.76 ± 0.05) were observed in group II 
disease control animals exposed to renal ischemia reperfusion (I/R) injury for 60 
minutes compared to group I normal animals with SOD (1.71 ± 0.04), CAT (1.38 ± 
0.07) and GSH levels (1.28 ± 0.04). Administration of methanol extract of Citrullus 
lanatus rind to group III and group IV animals at dose levels of 200 mg/kg and 400 
mg/kg for 6 days prior to renal ischemia reperfusion (I/R) injury significantly 
increased the SOD levels to 1.23±0.09 and 1.40 ± 0.09 (p<0.05 to p<0.001), catalase 
levels to 1.33 ± 0.09 and 1.46 ± 0.06 (p<0..001 to p<0.001) and GSH levels to 1.01 ± 
0.04 and 1.15 ± 0.05 (p<0.05 to p<0.001) respectively compared to group II disease 
control animals.  
Histopathology 
 Section of kidney from group I control animals showed normal cortex and 
medulla. The glomeruli, proximal and distal convoluted tubules, interstitium and 
vessels are unremarkable (Figure 9). 
 Section of kidney from group II disease control animals exposed to renal 
ischemia reperfusion (I/R) injury showed glomeruli with loss of shape, shrinking and 
increase in interstitium. Large areas of haemorrhage and edema also noted. The 
proximal convoluted tubules showed dilatation and shedding of epithelium indicating 
tubular necrosis. The distal convoluted tubules are markedly dilated and filled with 
eosinophilic material. Interstitium shows Congested (Figure 10).  
 Section from the kidney from group III animals treated with methanol extract 
of Citrullus lanatus rind 200 mg/kg for 6 days prior to  renal ischemia reperfusion 
(I/R) injury showed some of the glomeruli with loss of shape, Shrinking and increase 
in interstitium (fibrosis). The proximal convoluted tubules showed dilatation and 
shedding of epithelium indicating tubular necrosis. The distal convoluted tubules are 
markedly dilated at places filled with eosinophilic material. Interstitium shows 
Congested (Figure 11).  
 Section from kidney from group IV animals treated with methanol extract of 
Citrullus lanatus rind 400 mg/kg for 6 days prior to renal ischemia reperfusion (I/R) 
injury showed normal cortex and medulla. The glomeruli, proximal and distal 
convoluted tubules, interstitium and vessels are unmarkable. Focal 
lymphomononuclear infiltration noted (Figure 12).  
 
 
 
 
 
 
 
 
  
DISCUSSION 
   The present study demonstrates the renoprotective effect of Citrullus lanatus 
rind extract against ischemia-reperfusion induced acute renal failure. Renal ischemia 
is a major cause of acute renal failure and results in high rates of morbidity and 
mortality. Several mechanisms has been postulated to be involved in the mechanism 
of acute renal failure in ischemia/reperfusion injury. Ischemia reduces vasodialatory 
eNOS, thus compounding ischemia mediated renal injury through adversely altering 
the internal endothelin-1/NO balance. In the present study, Citrullus lanatus rind 
extract showed a significant renoprotective activity against ischemia/reperfusion acute 
renal injury. The renoprotective activity of Citrullus lanatus rind extract might be due 
to presence of citrulline, which has an important role in nitric oxide system to produce 
vasodialatory effect. 
  Generation of ROS has been postulated as one of the major factors 
contributing to reperfusion injury. After reperfusion and reoxgenation, the imbalance 
between restoration of oxygen supply and mitochondrial respiratory function results in 
massive generation of superoxide anion in mitochondria. Under these conditions, the 
defensive system, which is known as antioxidant or antioxidant enzymes, cannot 
prevent the escape of ROS, especially in mitochondria, and their effects on other 
intracellular sites. This cascade of events is known as reperfusion injury. 
As a free radical generating system, lipid peroxidation has been closely related 
with I/R induced tissue damage. ROS attach to the polyunsaturated fatty acids in the 
membrane lipids and results in lipid peroxidation, which In turns impacts enzymatic  
 processes ,such as ion-pump activity, inhibiting transcription and repair of DNA 
which will ultimately result in cell death. Since MDA is a good indicator of the degree 
of lipid peroxidation, in present study renal MDA was measured. A significant 
increase in MDA content was observed during I/R induced renal injury and our results 
show pretreatment with Citrullus lanatus rind extract significantly decreased the 
MDA levels, implying  a reduction in lipid peroxidation and cellular injury that 
protected the kidney against I/R induced oxidative damage . 
The enhanced formation of lipid peroxides is further evidenced by decrease in 
activities of antioxidant enzymes in  I/R induced renal  tissue damage. Antioxidants 
constitute the foremost defense that limit the toxicity associated with free radicals 
SOD is said to act as the first line defense against superoxide radical generated as a 
byproduct of oxidative phosphorylation. SOD mediated dismutation of superoxide 
radical generates H2O2. Accumulation of excess of H2O2 causes toxic effects on 
cellular system .In this regard, catalase detoxifics H2O2 in to water and oxygen. Thus 
SOD and catalase act mutually and constitute enzymatic defense against ROS. 
In the present study decrease in activities of SOD and catalase in kidney of I/R  
induced could be attributed  to excessive utilization of enzymes in detoxification of 
peroxides and hydroperoxides generated during oxidative stress. Restoration in the 
levels of lipid peroxidation upon treatment with Citrullus lanatus rind extract might 
have resulted in the recoupment in the activities of SOD and catalase to normally. 
Glutathione is known to be a major low molecular weight scavenger of free radicals in 
the cytoplasm. GSH is found to be present  in high concentration in cells, protects 
cells against free radical attack.GSH acts directly as free radical scavenger  by 
donating a hydrogen atom and there by neutralizing hydroxyl radical. It reduces 
 peroxides and maintain protein thiols in the reduced state. Glutathione peroxidase uses 
GSH as a substrate to catalyze the reduction of hydroperoxide and H2O2. Reduced 
glutathione in tissues maintains the cellular levels of vitamin C and vitamin E in active 
form. In the present study, the decrease level of non-enzymatic antioxidant GSH 
observed in kidney of I/R perfusion  might be due to excessive utilization of 
antioxidant for quenching enormous free radical produced. Treatment with Citrullus 
lanatus rind extract effectively restored the depleted levels of GSH.  
Citrullus lanatus is a rich source of lycopene, a carotenoid that has been 
reported to reduce oxidative stress in the kidneys might be responsible for 
cytoprotection against oxidative stress induced by I/R injury. 
Renal I/R- induced damage was associated with impaired kidney function, 
leading to marked increase in serum creatinine, urea and uric acid levels. Pretreatment 
with extract significantly decreased the creatinine, urea and uric acid level which 
indicates the protective effect of Citrullus lanatus rind extract. 
In invitro evaluation of Citrullus lanatus rind extract on isolated rat thoracic 
aortic rings a possible involvement of the endothelium derived factors in the 
vasorelaxant activity of Citrullus lanatus rind extract can be inferred, since it is well 
known that the vasoconstrictor effect of α1- adrenergic receptor agonists can be 
modulated by endothelium – derived relaxant factors such as endothelium derived 
nitric oxide and prostacyclin.  
The histopathological examination of kidney provided a supporting evidence 
for the results obtained from Invivo evaluation of renoprotective activity in 
experimental analysis. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 Conclusion 
CONCLUSION 
In conclusion, the findings of the current study illustrate that Citrullus 
lanatus rind extract, with its potent vasodilatory and free radical scavenging 
properties, seems to be a highly promising agent in protecting renal tissue against 
oxidative damage and in preventing renal dysfunction due to ischemia/reperfusion. 
The study has confirmed the presence of phytoconstituents such as aminoacids, 
proteins, alkaloids, phytosterols, flavonoids, saponins, diterpenes, phenolics, tannins, 
carbohydrate and glycosides. However, further studies should be performed to isolate the 
active principles responsible for nephroprotection and to elucidate the mechanism of 
nephroprotection. 
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